(SeaPRwire) - នៅឆ្នាំ១៦៥៤ ទស្សនវិទូ និងគណិតវិទូបារាំង Blaise Pascal បានពន្យល់ពីតក្កវិជ្ជានៃការជឿលើព្រះ ដែលបង្ហាញជាការភ្នាល់។ ការចំណាយទៅលើអ្នកជឿដែលដាក់ជំនឿខុសគឺតិចតួច ប៉ុន្តែតម្លៃនៃការមិនជឿប្រសិនបើព្រះមានពិតប្រាកដអាចនឹងគ្មានដែនកំណត់។ ដូច្នេះ Pascal បានលើកឡើងថា សម្រាប់អ្នកដើរតួសមហេតុផល ជម្រើសគឺច្បាស់ណាស់៖ ភ្នាល់លើព្រះ។ សព្វថ្ងៃនេះ យើងប្រឈមមុខនឹងការភ្នាល់ស្រដៀងគ្នានេះអំពីការមកដល់នៃបញ្ញាសិប្បនិម្មិតដែលមានសមត្ថភាពខ្ពស់ ប៉ុន្តែជាមួយនឹងភាពខុសគ្នាដ៏សំខាន់មួយ—ភស្តុតាងសម្រាប់ផលប៉ះពាល់នៃការផ្លាស់ប្តូររបស់ AI កំពុងកើនឡើងជារៀងរាល់ថ្ងៃ ហើយកាលបរិច្ឆេទដែលវាអាចកើតឡើងមិនមែនជាភាពអស់កល្បជានិច្ចនោះទេ ប៉ុន្តែក្នុងរយៈពេលប៉ុន្មានឆ្នាំខាងមុខនេះ។ ការភ្នាល់គឺនេះ៖ បញ្ញាសិប្បនិម្មិត (AI) នឹងផ្លាស់ប្តូរការងារ ការអប់រំ ក្រុមហ៊ុន និងសង្គមយ៉ាងខ្លាំងក្នុងរយៈពេលដ៏ខ្លី ឬក៏វានឹងមិនផ្លាស់ប្តូរ។ ប្រសិនបើយើងត្រៀមខ្លួនសម្រាប់ការផ្លាស់ប្តូរ ហើយវាមិនកើតឡើងទេ យើងទំនងជាបានវិនិយោគលើចំណេះដឹងឌីជីថល បានគិតឡើងវិញអំពីស្ថាប័នដែលរឹងមាំ និងបានពិចារណាជម្រើសសម្រាប់របៀបចែកចាយប្រាក់ចំណូលក្រៅពីប្រាក់ឈ្នួល។ ទាំងនេះមិនមែនជាការខាតបង់ដ៏មហន្តរាយនោះទេ។ ប៉ុន្តែប្រសិនបើយើងបរាជ័យក្នុងការត្រៀមខ្លួន ហើយការផ្លាស់ប្តូរមកដល់យ៉ាងឆាប់រហ័ស យើងប្រឈមនឹង , ហួសសម័យ , និង ។ ជម្រើសសមហេតុផលគឺច្បាស់។ យើងត្រូវតែភ្នាល់ថាការផ្លាស់ប្តូរនឹងកើតឡើង។ ពិចារណាទីផ្សារការងារ ដែលប្រហែលជាកំពុងជួបប្រទះនូវការរញ្ជួយដំបូងដែលបង្កឡើងដោយ AI ។ ទោះបីជាមានការបំផ្លើសក៏ដោយ មេដឹកនាំបច្ចេកវិទ្យាដូចជា , ស្ថាបនិកនិងនាយកប្រតិបត្តិរបស់ Anthropic, និង , អតីតនាយកប្រតិបត្តិរបស់ Google, នឹងលុបបំបាត់ការងារការិយាល័យកម្រិតដំបូងរហូតដល់ 50% ក្នុងរយៈពេលពីមួយទៅប្រាំឆ្នាំ។ អ្នកព្យាករណ៍ទាំងពីររូបនេះចូលរួមជាមួយក្រុមសេដ្ឋវិទូដែលកំពុងកើនឡើងយ៉ាងឆាប់រហ័ស រួមមាន Nobel laureate , omnipresent , និងអ្នកសិក្សា និងនាយកប្រតិបត្តិបច្ចេកវិទ្យាដ៏លេចធ្លោជាច្រើនទៀតដែល នៃការ“”ដែលជិតមកដល់។ ការឆ្លើយតបដ៏ងាយស្រួល—ខ្ញុំបានឮវាច្រើនដងហើយ—គឺថាក្នុងរយៈពេលរាប់ពាន់ឆ្នាំ សេដ្ឋកិច្ចបានឆ្លងកាត់ស្វ័យប្រវត្តិកម្មជាច្រើនដងពីមុនមក ហើយជាមួយនឹងការលោតផ្លោះបច្ចេកទេសនីមួយៗ ទីផ្សារការងារក៏សម្របខ្លួន។ បច្ចេកវិទ្យាថ្មីៗតែងតែនាំមកនូវរលកនៃតួនាទីការងារដែលមានប្រាក់ខែខ្ពស់ថ្មីៗដើម្បីជំនួសអ្វីដែលពួកគេលុបបំបាត់ចេញ មែនទេ? ប្រហែលជាមិនមែនពេលនេះទេ។ រលកនៃស្វ័យប្រវត្តិកម្មពីមុនភាគច្រើនបានជំនួសកម្លាំងសាច់ដុំ; លើកនេះវាជំនួសការវិនិច្ឆ័យ។ គិតមើលថាតើនឹងមានអ្វីកើតឡើងប្រសិនបើប្រព័ន្ធ AI ដែលអាចធ្វើមាត្រដ្ឋានបានយ៉ាងងាយស្រួលធ្វើឱ្យភាពវៃឆ្លាតរបស់មនុស្សក្លាយជាទំនិញ? យើងមិននិយាយអំពីការផ្លាស់ប្តូរបន្តិចម្តងៗនៃកម្មកររោងចក្រក្នុងរយៈពេលប្រហែល 100 ឆ្នាំ ឬការរំញោចទីផ្សារការងារតូចតាចដែលអាចដោះស្រាយបានជាមួយនឹងកម្មវិធីបណ្តុះបណ្តាលឡើងវិញសម្រាប់ការងារសេវាកម្មមួយចំនួននោះទេ។ យើងកំពុងនិយាយអំពីការផ្លាស់ប្តូរកម្លាំងពលកម្មការិយាល័យដ៏ធំមួយក្នុងរយៈពេលដ៏ខ្លីបំផុត។ ប្រសិនបើយើងខុសអំពីការផ្លាស់ប្តូរនេះ តើអ្វីទៅជាតម្លៃនៃការត្រៀមលក្ខណៈ? យើងប្រហែលជានឹងបង្កើតទីផ្សារការងារដែលកាន់តែបត់បែន ផលប្រយោជន៍ដែលអាចផ្ទេរបានដែលមិនជាប់ទាក់ទងនឹងការងារ និង ដែលអាចនឹងមិនចាំបាច់។ យើងនឹងបង្រៀនកុមារពីការគិតស៊ីជម្រៅ និងភាពច្នៃប្រឌិតជំនួសឱ្យការទន្ទេញ។ យើងនឹងជួយកម្មករបង្កើតជំនាញបំពេញបន្ថែម AI ។ ការវិនិយោគទាំងនេះមិនត្រូវបានខ្ជះខ្ជាយសូម្បីតែនៅក្នុងពិភពលោក "ស្ថិរភាព" ដែល AI មិនបានធ្វើឱ្យទីផ្សារការងារប្រែប្រួលក៏ដោយ។ ដោយមិនគិតពីផលប៉ះពាល់រយៈពេលវែងនៃ AI ប្រព័ន្ធអប់រំរបស់យើងត្រូវការកំណែទម្រង់ជាបន្ទាន់។ ប្រព័ន្ធបច្ចុប្បន្នរបស់យើងបណ្តុះបណ្តាលមនុស្សឱ្យធ្វើអ្វីដែល AI ធ្វើបានល្អបំផុត៖ ដំណើរការព័ត៌មាន គោរពតាមច្បាប់ ផលិតលទ្ធផលស្តង់ដារ។ ក្នុងករណីនោះ សាកលវិទ្យាល័យកំពុងបង្រៀនសិស្សរបស់ពួកគេឱ្យហួសសម័យ ហើយក្រោយមកទៀតកំពុងចំណាយប្រាក់យ៉ាងច្រើនសម្រាប់ឯកសិទ្ធិនេះ។ យើងគួរតែសង្កត់ធ្ងន់លើការវិនិច្ឆ័យក្រោមភាពមិនប្រាកដប្រជា ការវែកញែកផ្នែកសីលធម៌ ការដោះស្រាយបញ្ហាប្រកបដោយភាពច្នៃប្រឌិត និងការភ្ជាប់ទំនាក់ទំនងរបស់មនុស្ស—អ្វីក៏ដោយដែលយើងជឿថានៅតែមានកំណត់នៅពេលដែលភាពវៃឆ្លាតមានតាមតម្រូវការ។ វាមិនទាន់ចប់នៅទីនោះទេ។ ប្រព័ន្ធថែទាំសុខភាពត្រូវតែត្រៀមខ្លួនសម្រាប់ ក្រុមវេជ្ជសាស្រ្ត AI-មនុស្ស និងយន្តការទទួលខុសត្រូវសម្រាប់អ្នកសម្រេចចិត្តតាមក្បួនដោះស្រាយ។ ទីផ្សារហិរញ្ញវត្ថុប្រហែលជាត្រូវការ សម្រាប់ពាណិជ្ជករ AI ។ ទីក្រុងត្រូវតែរៀបចំផែនការសម្រាប់ ដែលនឹងលុបបំបាត់ការងារបើកបររាប់លាន។ តុលាការត្រូវការក្របខ័ណ្ឌសម្រាប់ពេលដែលភ្នាក់ងារចុះកិច្ចសន្យា បង្កើតអ្វីដែលត្រូវបានប៉ាតង់ ឬប្រព្រឹត្តបទឧក្រិដ្ឋ។ យើងក៏ត្រូវតែត្រៀមខ្លួនសម្រាប់ពិភពលោកដែលសមត្ថភាពរបស់ AI អាចត្រូវបានប្រើសម្រាប់ការគំរាមកំហែង—ការវាយប្រហារតាមអ៊ីនធឺណិត ការលួចអត្តសញ្ញាណ និងការរៀបចំផែនការវាយប្រហារភេរវកម្ម។ ជាការសំខាន់ យើងត្រូវការរឿងនិទានថ្មីអំពីតម្លៃរបស់មនុស្សដែលពឹងផ្អែកតិចលើការងារ និងដែលគិតគូរពីការរីករាលដាលពេញលេញនៃ AI នៅក្នុងជីវិតរបស់យើង។ នៅពេលដែលម៉ាស៊ីនគិតបានល្អជាង ធ្វើការបានល្អជាង និងសូម្បីតែបង្កើតបានល្អជាងមនុស្ស ប៉ុន្តែក៏ក្លាយជាភាគីផ្ទុយគ្នាក្នុងទំនាក់ទំនងដ៏សំខាន់ជាច្រើនរបស់យើង តើអ្វីផ្តល់អត្ថន័យដល់ជីវិត? ជាថ្មីម្តងទៀត ប្រសិនបើយើងខុសអំពី AI យើងបានធ្វើការឆ្លុះបញ្ចាំងទស្សនវិជ្ជាដែលមានសុខភាពល្អ។ ប្រសិនបើយើងត្រូវ ហើយមិនបានត្រៀមខ្លួនខាងទស្សនវិជ្ជា ចិត្តសាស្ត្រ និងវប្បធម៌ទេ យើងប្រឈមមុខនឹងវិបត្តិនៃគោលបំណងដែលអាចបង្ហាញជាភាពតានតឹងផ្លូវចិត្តដ៏ធំ ឬអាក្រក់ជាងនេះ។ អ្នកខ្លះអះអាងថាការរីកចម្រើនរបស់ AI បាន , ថាបទប្បញ្ញត្តិ នឹង និងថាមនុស្សនឹងតែងតែរក្សាបាននូវ ។ ប្រហែលជា។ ប៉ុន្តែតក្កវិជ្ជារបស់ Pascal នៅតែមាន៖ ភាពមិនស៊ីសង្វាក់គ្នានៃលទ្ធផលទាមទារសកម្មភាព។ ទំនងជាមានអត្ថប្រយោជន៍នៃការត្រៀមខ្លួនសម្រាប់ការផ្លាស់ប្តូរទោះបីជាវាមិនកើតឡើងក៏ដោយ។ តម្លៃនៃការមិនត្រៀមខ្លួនសម្រាប់ការផ្លាស់ប្តូរដែលកើតឡើងនឹងមានទំហំធំធេងណាស់។ Pascal បានភ្នាល់លើរឿងអស់កល្បជានិច្ច។ ការភ្នាល់ AI គឺទាក់ទងនឹងអនាគតដ៏ខ្លី។ ភាគហ៊ុនសម្រាប់បុគ្គលណាម្នាក់អាចទាបជាងក្នុងករណីនេះ ប៉ុន្តែមិនដូចព្រះរបស់ Pascal ការមកដល់របស់ AI នឹងមិនរង់ចាំថ្ងៃជំនុំជំរះនោះទេ។ វាកំពុងគោះទ្វារហើយ។ នៅក្នុងការភ្នាល់នេះ លទ្ធផលអាក្រក់មិនមែនជាការដែល AI ធ្វើឱ្យខកចិត្តនោះទេ។ វាគឺថាវាបំពេញគ្រប់ការសន្យា ខណៈដែលយើងនៅតែជជែកគ្នាថាតើត្រូវជឿថានេះកំពុងកើតឡើងឬអត់។ ដាក់ភ្នាល់របស់អ្នកតាមនោះ។ អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
ការតស៊ូដែលកំពុងកើនឡើងចំពោះការបណ្តេញចេញទ្រង់ទ្រាយធំ
(SeaPRwire) - ខណៈពេលដែលមនុស្សជាច្រើនបានសង្ស័យថា ការបណ្តេញចេញទ្រង់ទ្រាយធំដែលលោក Trump បានលើកឡើងក្នុងយុទ្ធនាការឃោសនាបោះឆ្នោតប្រធានាធិបតីរបស់គាត់នឹងក្លាយជាការពិត វាច្បាស់ណាស់ថារដ្ឋបាលនៅតែរក្សាពាក្យសម្ដីរបស់ខ្លួន ដោយប្រើប្រាស់គ្រប់មធ្យោបាយដើម្បីបណ្តេញជនអន្តោប្រវេសន៍ខុសច្បាប់ឱ្យបានលឿនបំផុត។ កិច្ចខិតខំប្រឹងប្រែងបណ្តេញចេញមួយចំនួនទាំងនេះមានចេតនា ដូចជាការបើក Alligator Alcatraz។ កិច្ចខិតខំប្រឹងប្រែងផ្សេងទៀតគឺ ដូចជាការបណ្តេញលោក Kilmar Abrego Garcia ទៅកាន់ប្រទេស El Salvador។ ហើយទាំងអស់នេះបានបណ្តាលឱ្យមាន , ផលវិបាកសេដ្ឋកិច្ច និងសង្គមដែលនឹងបន្តកើតមានអស់ជាច្រើនទសវត្សរ៍។ ទោះជាយ៉ាងណា សហគមន៍បានបដិសេធមិនឈរមើលដោយស្ងៀមស្ងាត់ឡើយ។ ពីទីក្រុងធំៗដូចជា Los Angeles ដល់ទីក្រុងជនបទតូចៗដូចជា O’Neill, Neb. សហគមន៍បានរួបរួមគ្នាដោយមិនប្រកាន់ជាតិសាសន៍ វណ្ណៈ ស្ថានភាពអន្តោប្រវេសន៍ និងនិន្នាការនយោបាយ ដើម្បីទប់ទល់នឹងភាពឃោរឃៅ និងភាពវឹកវរនៃការបណ្តេញចេញទ្រង់ទ្រាយធំ។ ក្នុងអំឡុងពេលរដ្ឋបាលលោក Trump លើកទីមួយ ខ្ញុំបានទៅទស្សនាទីក្រុងនានាទូទាំងប្រទេសដែលរងការវាយប្រហារដោយការឆ្មក់ចូលកន្លែងធ្វើការទ្រង់ទ្រាយធំ—ការឆ្មក់ចូលដូចជាអ្វីដែលបានកើតឡើងនៅក្នុង . ពេលកម្មករ ៤៧៥ នាក់ត្រូវបាននាំចេញពីរោងចក្រ Hyundai កាលពីថ្ងៃទី ៤ ខែកញ្ញា ឆ្នាំ ២០២៥។ ជាមួយក្រុមនិស្សិតសុខភាពសាធារណៈតូចមួយ រួមជាមួយមិត្តរួមការងារ និងខ្ញុំ បាននិយាយជាមួយប្រជាជនពីទីក្រុងជនបទតូចៗទាំងនេះដែលភាគច្រើនជាជនជាតិស្បែកស។ ការឆ្មក់ចូលរបស់អន្តោប្រវេសន៍ ដូចជាទម្រង់នៃការបណ្តេញចេញទាំងអស់ គឺ។ ប៉ុន្តែខ្ញុំមិនត្រឹមតែឮរឿងរ៉ាវនៃគ្រោះមហន្តរាយ និងការដួលរលំឡើយ។ ខ្ញុំក៏បានឮរឿងរ៉ាវនៃការលះបង់ និងភាពក្លាហានផងដែរ—រឿងរ៉ាវដែលនៅចំពេលមានការប៉ុនប៉ងយ៉ាងច្បាស់លាស់ដើម្បីពណ៌នាជនអន្តោប្រវេសន៍ Latino ថាជាអ្នកលួចការងារដ៏ហិង្សា បានរំឭកខ្ញុំអំពីការតាំងចិត្ត ភាពច្នៃប្រឌិត និងការជំរុញទឹកចិត្តរបស់គ្រួសារអន្តោប្រវេសន៍។ ទីតាំងដំបូងដែលយើងបានទៅទស្សនាគឺស្ថិតនៅក្នុង Morristown, Tenn. ដែលជាស្រុកតូចមួយមានប្រជាជនប្រហែល ៣២.០០០ នាក់នៅក្បែរកន្លែង ក្នុងខែមេសា ឆ្នាំ ២០១៨។ ពេលវេលារបស់ខ្ញុំនៅទីនោះបានបង្ហាញការពិតជាមូលដ្ឋានមួយចំនួនអំពីការបណ្តេញចេញ ដែលទោះបីជាជាក់ស្តែងនៅពេលក្រោយក៏ដោយ ក៏ត្រូវបានខកខានបានយ៉ាងងាយស្រួលនៅក្នុងការនិទានរឿងសាធារណៈនៃការបណ្តេញចេញ។ ទីមួយ ការអនុវត្តច្បាប់អន្តោប្រវេសន៍បណ្តាលឱ្យមានការអត់ឃ្លានយ៉ាងខ្លាំង។ នេះអាចបណ្តាលមកពីអ្នករកស៊ីចិញ្ចឹមគ្រួសារសំខាន់ត្រូវបានបណ្តេញចេញ ហើយក្រុមគ្រួសាររបស់ពួកគេមិនមានលទ្ធភាពទិញអាហារ ឪពុកម្តាយដែលនៅសល់ខ្លាចពេកមិនហ៊ានចាកចេញពីផ្ទះ ឬ ដូចដែលយើងបានឃើញនៅ Tennessee កុមារឈប់ទៅសាលារៀនហើយមិនបរិភោគនៅក្នុងអាហារដ្ឋានទេ។ ទីពីរ លើកលែងតែករណីមួយចំនួន ការឆ្មក់ចូលកន្លែងធ្វើការរបស់អន្តោប្រវេសន៍កើតឡើងនៅពេលថ្ងៃ ខណៈដែលកុមារ និងក្មេងជំទង់នៅសាលារៀន។ នេះមានន័យថា គ្រូៗត្រូវពន្យល់សិស្សរបស់ពួកគេថា ឪពុកម្តាយដែលបានទម្លាក់ពួកគេនៅសាលាប្រហែលជាមិនមែនជាអ្នកដែលទៅទទួលពួកគេនោះទេ ដែលជាស្ថានភាពដែលយើងកំពុងជួបប្រទះក្នុងឆ្នាំ ២០២៥។ នៅ Morristown គ្រូៗមានការខឹងសម្បារយ៉ាងខ្លាំងចំពោះអវត្តមានដ៏ច្រើនសន្ធឹកសន្ធាប់ ដែល ដោយអ្នកសារព័ត៌មាន New Yorker លោក Jonathan Blitzer នោះ ពួកគេបានបង្កើតប្រព័ន្ធដឹកជញ្ជូនអាហារផ្ទាល់ខ្លួន ដោយយកអាហារថ្ងៃត្រង់ខ្ចប់ទៅផ្ទះរបស់សិស្សដែលអវត្តមានដោយផ្ទាល់។ ក្នុងចំណោមភាពចម្លែកនៃការអនុវត្តច្បាប់អន្តោប្រវេសន៍គឺថា បន្ទាប់ពីជនអន្តោប្រវេសន៍ត្រូវបានឃុំខ្លួន មនុស្សជាច្រើនត្រូវបានដោះលែងដើម្បីរង់ចាំករណីបណ្តេញចេញរបស់ពួកគេ។ នេះបណ្តាលឱ្យមានស្ថានភាព Catch-22: ទោះបីជាពួកគេមិនអាចបើកបរស្របច្បាប់ក៏ដោយ រដ្ឋាភិបាលសហព័ន្ធស្នើឱ្យពួកគេបង្ហាញខ្លួននៅទីតាំងមួយចំនួនដើម្បីធ្វើរឿងរ៉ាវដូចជា ការចុះឈ្មោះជាមួយ ICE ការបំពេញឯកសារ ការផ្តល់ហត្ថលេខា និងស្នាមមេដៃ ឬការបញ្ចប់ទម្រង់អនុម័តរបស់វេជ្ជបណ្ឌិត។ នៅក្នុងរដ្ឋជនបទ ទីតាំងដែលត្រូវទៅទស្សនាអាចនៅឆ្ងាយជាងមួយម៉ោង ឆ្លងកាត់ស្រុក ឬសូម្បីតែព្រំដែនរដ្ឋ។ នៅខែមិថុនា ឆ្នាំ ២០១៨ ICE បានឆ្មក់ចូលកន្លែងបណ្តុះកូនរុក្ខជាតិ និងរោងចក្រកែច្នៃសាច់នៅក្នុងទីក្រុង Ohio ពីរគឺ និង។ កម្មករ ២៦០ នាក់ត្រូវបានឃុំខ្លួន។ ស្ទើរតែភ្លាមៗ អ្នករៀបចំបានបង្កើតប្រព័ន្ធជិះរួមគ្នា ដែលភាគច្រើនមានបុគ្គលិកជាអ្នកចូលនិវត្តន៍ដែលមានការរួមបញ្ចូលគ្នាយ៉ាងជាក់លាក់នូវអ្វីដែលត្រូវការនៅពេលនោះ៖ ប្រតិទិនបើកចំហសម្រាប់ការបើកបរប្រាំបីម៉ោង ប័ណ្ណបើកបរ និងស្បែកសដែលនឹងការពារ ។ យូរៗទៅ ប្រជាជនជនបទស្បែកសបានធ្វើការរួមគ្នាជាមួយអ្នកជិតខាងជនអន្តោប្រវេសន៍ Latino របស់ពួកគេ។ ឧទាហរណ៍ តែប៉ុន្មានម៉ោងបន្ទាប់ពីការឆ្មក់ចូល ព្រះវិហារនានាបានបើកទ្វាររបស់ពួកគេដើម្បីឱ្យអ្នកកាន់សាសនាដែលភ័យខ្លាចពេកមិនហ៊ានត្រឡប់ទៅផ្ទះអាចគេងនៅក្នុងកៅអីព្រះវិហារ។ នៅក្នុងព្រះវិហារមួយដែលខ្ញុំបានទៅទស្សនានៅ Mount Pleasant, Iowa បន្ទប់បន្ថែមមួយបានក្លាយពីឃ្លាំងអាហារទៅជាមន្ទីរពិសោធន៍ភាសា ដែលអ្នកដែលបានមកព្រះវិហារអាចប្រើកុំព្យូទ័រដើម្បីរៀនភាសាអង់គ្លេស។ ព្រះវិហារជាច្រើនទាំងនេះបានក្លាយជាបង្គោលភ្លើងហ្វារដែលអ្នកស្ម័គ្រចិត្តបានហូរចូល ហើយមិនយូរប៉ុន្មាន មេធាវីបានចាកចេញពីទីក្រុងធំៗរបស់ពួកគេ ហើយបើកបររាប់ម៉ោងទៅកាន់ព្រះវិហារទាំងនេះ បោះតង់សម្រាប់ចុងសប្តាហ៍ ហើយធ្វើការរហូតដល់យប់ដើម្បីធានាថាអ្នករាល់គ្នាដឹងថាអ្នកជាទីស្រឡាញ់ដែលត្រូវបានឃុំខ្លួនរបស់ពួកគេនៅឯណា ហើយថាពួកគេម្នាក់ៗមានតំណាងផ្នែកច្បាប់។ នៅពេលដែលសមាជិកសហគមន៍បានមកជាមួយបញ្ហាអន្តោប្រវេសន៍ដែលមិនទាក់ទង មេធាវីបានជួយ។ យុទ្ធសាស្ត្រតស៊ូបានចាប់ផ្តើមជាបញ្ហានៃការរស់រានមានជីវិត ប៉ុន្តែប្រព័ន្ធទាំងនោះបានរីកចម្រើន វិវឌ្ឍន៍ ហើយថែមទាំងបានលើកកម្ពស់សុច្ឆន្ទៈដោយមិនប្រកាន់ជាតិសាសន៍ វណ្ណៈ ហើយក្នុងករណីជាច្រើន និន្នាការនយោបាយផងដែរ។ ដែលមានប្រជាជនប្រហែល ៣.៥០០ នាក់ ដែលក្នុងនោះមានតែ ៥០០ នាក់ជាជនជាតិ Latino ស្រដៀងនឹងទីក្រុងតូចៗជាច្រើនផ្សេងទៀតដែលរាយប៉ាយនៅផ្នែកខាងក្នុងនៃសហរដ្ឋអាមេរិក ហើយក៏ជួបប្រទះនឹងកិច្ចខិតខំប្រឹងប្រែងបណ្តេញចេញគោលដៅផងដែរ។ សហគមន៍តូចៗទាំងនេះ ដែលមានជនអន្តោប្រវេសន៍តិច និងមនុស្សតិចតួចដែលស្គាល់ជនអន្តោប្រវេសន៍ ជារឿយៗខ្វះកម្លាំងមនុស្សដើម្បីប្រមូលផ្តុំការតវ៉ាទ្រង់ទ្រាយធំដែលយើងបានឃើញនៅក្នុង ។ ហើយខណៈដែលទីក្រុងដែលដឹកនាំតាមបែបប្រជាធិបតេយ្យដូចជា New York មានមន្ត្រីជាប់ឆ្នោត ប្រសិនបើពួកគេមិនត្រូវបានអនុញ្ញាតឱ្យស៊ើបអង្កេតបន្ទប់ឃុំខ្លួន ICE នោះទេ ទីក្រុងជនបទនៅក្នុងស្រុកក្រហមទំនងជាមាននាយប៉ូលិសដែលយល់ព្រមយ៉ាងសកម្មក្នុងការធ្វើការជាមួយ ICE។ ទីក្រុងដែលភាគច្រើនជាជនជាតិស្បែកស ជារឿយៗក៏ខ្វះក្រុមវប្បធម៌នៃទីក្រុងធំៗផងដែរ ដូចជាក្រុមតន្រ្តី mariachi ដែលបានប្រកបដោយភាពច្នៃប្រឌិត ពីភ្នាក់ងារ ICE ដែលគ្រោងនឹងចាប់ខ្លួនក្រុមគ្រួសាររបស់ពួកគេនៅព្រឹកស្អែក។ កិច្ចខិតខំប្រឹងប្រែងបណ្តេញចេញទ្រង់ទ្រាយធំកំពុងកើនឡើង។ ប៉ុន្តែកិច្ចខិតខំប្រឹងប្រែងដើម្បីទប់ទល់នឹងវា និងដើម្បីរក្សាគ្រួសារ និងសហគមន៍ឱ្យមានសុខភាពល្អ រីករាយ និងពេញលេញក៏កំពុងកើនឡើងដែរ។ អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
Bamboos Announces 2025 Annual Results
HONG KONG, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Bamboos Health Care Holdings Limited ("Bamboos" or the "Group", Stock Code: 2293) announced its annual results for the year ended 30 June 2025 (the "Period" or the "Year") on September 30th. The Group's overall business remained stable during the year, continuing its consistent focus on shareholder returns, and declared a final dividend for 2025 of HK1.50 cents per ordinary share.During the Period, the Group's revenue was approximately HK$74.4 million. The revenue from the provision of healthcare staffing solution services was approximately HK$61.7 million, comprising approximately HK$35.2 million from institutional staffing solution services and approximately HK$26.5 million from private nursing staffing services. Other income increased year-on-year to HK$1.6 million. Profit before income tax was approximately HK$22.4 million. Profit attributable to equity holders of the Company for the year amounted to approximately HK$17.5 million. Finance income increased year-on-year to approximately HK$1.6 million for the year. Total assets remained stable, with current assets maintaining a healthy level.Furthermore, during the year, the Group also utilized idle cash balances to acquire SPDR Gold Trust, which is a standalone investment trust and an exchange trade fund which holds gold bullion (the "Acquisitions"), enhancing the efficiency of utilizing the Group's idle cash. The Board considers that the Acquisitions provide the Group with opportunity to balance and diversify its investment portfolio, as well as protecting the Group from currency debasements and inflation in times of uncertainty.As of 30 June 2025, the number of healthcare personnel registered with the Group increased by 7.4% year-on-year to approximately 32,000, from 29,800 in the same period last year. This steadily growing, large, and diverse pool of registered healthcare personnel not only demonstrates the Group's favorable benefits and talent retention rate but will also help the Group further enhance its competitive strength and seize business development opportunities.Actively Advances Integration of 'Technology+Innovation' with Healthcare, New 'Bamboos Health' Ecosystem Holds Broad Development SpaceWith healthcare staffing solutions at its core, Bamboos provides professional, comprehensive, reliable, and customized institutional support services and home care nursing solutions for the Hospital Authority, private hospitals, social welfare organizations, clinics, and research medical institutions. While steadfastly maintaining its core business in recent years, the Group has actively promoted the integration of "Technology + Innovation" with healthcare, continuously optimizing service quality and efficiency, deepening business cooperation, and expanding business scope. By integrating three major service sectors – Preventive Medicine, Chinese and Western Medical Services, and Smart Elderly Care and Age-Friendly Living Solutions – the Group has built a new "Bamboos Health" ecosystem.During the year, the Group also actively utilized its self-owned physical space in Mong Kok, and has established a service platform integrating healthcare, smart home AI elderly care technology, and data – "healtHUB". It has evolved from initially providing healthcare staffing solutions into a health technology ecosystem platform covering the full lifecycle of "Prevention-Treatment-Rehabilitation-Home Care-Smart Elderly Care", providing a one-stop healthcare and smart home service solution empowered by "Technology + Innovation".Given the ongoing trends of population ageing and healthcare manpower shortages, coupled with the broad prospects of the global AI healthcare market, Bamboos' focus on "Technology + Innovation" empowerment and its business coverage of the full lifecycle aligns with healthcare industry development trends. Simultaneously, the Group actively responds to national and government policies, echoing China's "Healthy China 2030" Plan Outline and supporting the development of Hong Kong's Primary Healthcare system. This not only allows multiple business lines to benefit from long-term policy support and access stable government business resources but also creates synergies with other operations, presenting Bamboos Health Care with extensive, stable business demand and medium-to-long-term sustainable growth potential.Ms. Hai Hiu Chu, Chairman and Chief Executive Officer of Bamboos Group, said, "Bamboos will continue to dedicate itself to strengthening and consolidating its core business and becoming a more renowned market leader, while actively seeking new business opportunities, advancing the integration of 'Technology + Innovation' with healthcare, and forming alliances or partnerships with strategic collaborators to pursue greater diversification of the Group's business, supporting Bamboos' sustainable growth and the strategy of maximizing shareholder returns."About Bamboos Health Care Holdings LimitedBamboos Health Care Holdings Limited provides a one-stop healthcare and smart home service solution empowered by "Technology + Innovation". Since its establishment in 2009, the Group has always adhered to the service philosophy of "Care • Competence • Commitment". In recent years, while steadfastly maintaining its core business, the Group has promoted the integration of "Technology + Innovation" with healthcare, continuously optimizing service quality and efficiency, deepening business cooperation, and expanding business scope. By integrating three major service sectors – Preventive Medicine, Chinese and Western Medical Services, and Smart Elderly Care and Age-Friendly Living Solutions – the Group has built a new "Bamboos Health" ecosystem. The Group also actively utilized its self-owned physical space in Mong Kok, establishing a service platform integrating healthcare, smart home AI elderly care technology, and data – " healtHUB". The Group has now evolved from initially providing healthcare staffing solutions into a health technology ecosystem platform covering the full lifecycle of "Prevention-Treatment-Rehabilitation-Home Care-Smart Elderly Care".With healthcare staffing solutions at its core, Bamboos boasts a network of over 32,000 qualified professional healthcare personnel, providing professional, comprehensive, reliable, and customized institutional support services and home care nursing solutions for the Hospital Authority, private hospitals, social welfare organizations, clinics, and research medical institutions. To date, the Group has served over 3,500 nursing homes / rehabilitation centres / clinics. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Production, Sales and Export Results for August, 2025
TOKYO, Sept 29, 2025 - (JCN Newswire via SeaPRwire.com) - Honda Motor Co., Ltd. today announced a summary of automobile production, Japan domestic sales, and export results for the month of August 2025.World Production August 2025YOYAugust 2024Jan.- Aug. 2025YOYJan.- Aug. 2024Japan44,586 units88.4%50,431 units438,531 units98.5%445,317 unitsOutside of Japan222,419 units86.7%256,602 units1,842,490 units90.2%2,042,347 unitsTotal267,005 units87.0%307,033 units2,281,021 units91.7%2,487,664 unitsProduction in Main Regions North America136,559 units94.9%143,859 units1,072,896 units97.7%1,098,456 units USA88,056 units93.9%93,777 units650,390 units94.7%686,567 units Asia76,887 units74.3%103,526 units705,971 units79.6%886,392 units China50,011 units80.5%62,151 units423,209 units77.3%547,704 unitsAugust 2025- Production in Japan: 1st YOY decrease in 3 months- Production outside Japan: 13th consecutive month of YOY decrease - Worldwide production: 13th consecutive month of YOY decreaseSales in the Japanese Market August 2025YOYAugust 2024Jan.- Aug. 2025YOYJan.- Aug. 2024Total41,220 units89.9%45,868 units413,353 units92.4%447,432 unitsRegistrations21,038 units82.0%25,657 units230,547 units88.1%261,803 unitsMini-vehicles20,182 units99.9%20,211 units182,806 units98.5%185,629 unitsAugust 2025- Total sales in Japan: 5th consecutive month of YOY decrease- New vehicle registrations: 10th consecutive month of YOY decrease- Sales of mini-vehicles: 4th consecutive month of YOY decreaseExports from Japan August 2025YOYAugust 2024Jan.- Aug. 2025YOYJan.- Aug. 2024 Total7,307 units126.9%5,756 units68,609 units124.0%55,337 units North America2,037 units270.2%754 units16,754 units425.6%3,937 units USA1,727 units236.6%730 units15,837 units415.3%3,813 units Asia277 units97.5%284 units3,238 units110.1%2,942 units Europe2,551 units98.0%2,603 units27,128 units85.2%31,859 units Others2,442 units115.5%2,115 units21,489 units129.5%16,599 unitsAugust 2025- Total exports from Japan: 5th consecutive month of YOY increase Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
ហេតុអ្វី ‘ការខិតខំប្រឹងប្រែងខ្លាំងពេក’ មិនមានប្រសិទ្ធភាព៖ សៀវភៅថ្មីអំពាវនាវឱ្យមានបដិវត្តន៍ក្នុងការកំណត់និយមន័យនៃការពង្រឹងអំណាច
(SeaPRwire) - ដោយផ្អែកលើការយល់ដឹងពីវិស័យវេជ្ជសាស្ត្រ ភាពជាអ្នកដឹកនាំ និងការបង្វឹក លោកបណ្ឌិត Stacey Kevin Frick ផ្ដល់នូវផែនការថ្មីមួយសម្រាប់ការរីកចម្រើនលើសពីភាពនឿយហត់ និងការភ័យខ្លាច។ម៉ៃអាមី រដ្ឋផ្លរីដា ថ្ងៃទី ២៩ ខែកញ្ញា ឆ្នាំ ២០២៥ - សៀវភៅថ្មីដែលមានចំណងជើងថា The Empowerment Revolution ជំទាស់នឹងគំនិតប្រពៃណីអំពីភាពជោគជ័យ និងណែនាំអ្នកអានឆ្ពោះទៅរកទំនុកចិត្តលើខ្លួនឯង ភាពច្បាស់លាស់ និងគោលបំណងយូរអង្វែង Red Thread Publishing ប្រកាសពីការចេញផ្សាយទូទាំងប្រទេសនូវសៀវភៅ The Empowerment Revolution: From Self-Doubt to Self-Made ដោយលោកបណ្ឌិត Stacey Kevin Frick ដែលជាស្នាដៃមិនមែនប្រឌិតដ៏ក្លាហាន និងទាន់ពេលវេលា ដែលកំណត់និយមន័យថ្មីនៃការផ្តល់សិទ្ធិអំណាច ភាពជោគជ័យ និងការផ្លាស់ប្តូរផ្ទាល់ខ្លួនសម្រាប់ពិភពលោកបច្ចុប្បន្ន។ ដោយទាញយកបទពិសោធន៍ជាង ២០ ឆ្នាំក្នុងវិស័យវេជ្ជសាស្ត្រ ភាពជាសហគ្រិន និងការបង្វឹក លោកបណ្ឌិត Frick បញ្ចូលគ្នាទាំងរឿងរ៉ាវផ្ទាល់ខ្លួន ការយល់ដឹងពីវិជ្ជាជីវៈ និងយុទ្ធសាស្ត្រជាក់ស្តែង ដើម្បីបង្កើតផែនការដ៏មានឥទ្ធិពលមួយសម្រាប់អ្នកណាម្នាក់ដែលត្រៀមខ្លួនរួចជាស្រេចដើម្បីបោះជំហានហួសពីភាពនឿយហត់ និងការសង្ស័យលើខ្លួនឯង។ ជាមួយនឹងបុព្វកថាដោយអ្នកនិយាយលើកទឹកចិត្តដ៏ល្បីល្បាញ Lisa Nichols សៀវភៅ The Empowerment Revolution អញ្ជើញអ្នកអានឱ្យឈានចូលទៅក្នុងភាពច្បាស់លាស់ ទំនុកចិត្ត និងគោលបំណងពិតប្រាកដ។ លោកបណ្ឌិត Frick មានប្រសាសន៍ថា «ការផ្តល់សិទ្ធិអំណាចពិតប្រាកដមិនមែនជាការខិតខំប្រឹងប្រែងខ្លាំងជាងមុន ឬការដេញតាមភាពជោគជ័យតាមបែបអ្នកដទៃនោះទេ។ វាគឺអំពីការភ្ជាប់ឡើងវិញជាមួយអំណាចផ្ទាល់ខ្លួនរបស់អ្នក ការសរសេររឿងរ៉ាវចាស់ៗឡើងវិញ និងការជ្រើសរើសរស់នៅដោយចេតនា។» ត្រូវបានកោតសរសើររួចហើយដោយអ្នកដឹកនាំគំនិត និងអ្នកពិនិត្យដំបូង រួមទាំងលោក Jack Canfield ដែលជាសហអ្នកនិពន្ធសៀវភៅ Chicken Soup for the Soul និង The Success Principles ដែលបានហៅវាថា «ជាថ្នាក់មេដែលចាំបាច់បំផុតសម្រាប់ការផ្តល់សិទ្ធិអំណាចផ្ទាល់ខ្លួន» សៀវភៅ The Empowerment Revolution លេចធ្លោជាសៀវភៅដែលត្រូវតែអាននៅក្នុងចលនាកំពុងរីកចម្រើនសម្រាប់ភាពពិតប្រាកដ ការរស់នៅដោយចេតនា និងភាពជោគជ័យដ៏ទូលំទូលាយ។ សៀវភៅនេះរួមបញ្ចូលទាំងបុព្វកថាដោយ Lisa Nichols ។ អំពីអ្នកនិពន្ធ លោកបណ្ឌិត Stacey Kevin Frick គឺជាអ្នកដឹកនាំដែលមានចក្ខុវិស័យ ដែលបានលះបង់ដើម្បីលើកកម្ពស់សុខភាព សុខុមាលភាព និងការផ្តល់សិទ្ធិអំណាចផ្នែកហិរញ្ញវត្ថុ។ ជាមួយនឹងបទពិសោធន៍រាប់ទសវត្សរ៍ក្នុងនាមជាអ្នកជំនាញផ្នែកវេជ្ជសាស្ត្រ សហគ្រិន និងជានាយកប្រតិបត្តិ លោកឥឡូវនេះផ្តល់អំណាចដល់បុគ្គលទូទាំងពិភពលោកឱ្យបញ្ចេញសក្តានុពលពេញលេញរបស់ពួកគេ។ ក្នុងនាមជាអ្នកនិពន្ធ គ្រូបង្វឹក និងវាគ្មិនដ៏ល្បីម្នាក់ លោកបណ្ឌិត Frick មានជំនាញពិសេសផ្នែកទំនុកចិត្តលើខ្លួនឯង ភាពវៃឆ្លាតផ្នែកអារម្មណ៍ និងការលូតលាស់ផ្លាស់ប្តូរ។ លោកគឺជាស្ថាបនិកនៃវេទិកា The Empowerment Revolution ដែលជាចលនាដែលត្រូវបានរចនាឡើងដើម្បីជួយមនុស្សបង្កើតជីវិតដែលពោរពេញដោយក្តីរីករាយ ភាពបរិបូរណ៍ និងឥទ្ធិពល។ សៀវភៅ The Empowerment Revolution: From Self-Doubt to Self-Made មានលក់ហើយនៅគ្រប់ទីកន្លែងដែលលក់សៀវភៅ រួមទាំង។គេហទំព័រ៖ ទំនាក់ទំនងប្រព័ន្ធផ្សព្វផ្សាយRed Thread Publishing8026881171 ប្រភព :Red Thread Publishing អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
NEC Releases Third Edition of TNFD Report
TOKYO, Japan, September 29, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has published the third edition of its report summarizing business risks and opportunities related to natural capital, aligned with the recommendations of the Taskforce on Nature-related Financial Disclosures (TNFD).In creating this report, NEC significantly enhanced the comprehensiveness of site analysis by leveraging the expertise and know-how of its specialized personnel and incorporating it into generative AI and agentic AI. Specifically, NEC analyzed local risks related to water infrastructure at each analysis site—risks that were difficult to grasp using conventional generic tools. Moreover, communication materials were automatically generated and the number of sites subject to detailed analysis were expanded to approximately 2,000 (*1). This enabled dialogue with local stakeholders based on actual conditions. Going forward, NEC plans to further deepen engagement with upstream partners in the value chain.NEC TNFD Report, Third Edition URL: https://www.nec.com/en/global/sustainability/eco/pdf/NEC-tnfd-en.pdfIn recent years, demand for global disclosure of information on sustainability has rapidly intensified. This requires companies to possess specialized knowledge and handle significant workloads. NEC, with the realization of a sustainable society as its Purpose, is actively engaged in this field.Since publishing Japan's first TNFD report in the IT industry in July 2023, NEC has continued its proactive activities, including issuing the second edition of its TNFD report in June 2024 (*2), which reflects the TNFD Final Recommendations v1.0. NEC also contributes to the development of international schemes, participating in activities that include the creation of IT sector guidance for use by the World Economic Forum (*3) and collaborating with TNFD's Nature Data Public Facility (NDPF, (*4)). Insights gained from these experiences are woven into this report. Furthermore, this TNFD report leverages generative AI and agentic AI. Treating NEC itself as "client zero," the company first thoroughly utilizes advanced technologies internally, then applies the resulting know-how and insights to help solve customer challenges. This is used not merely for disclosure purposes, but as a tool for minimizing risks and maximizing opportunities.Benefits of Utilizing Generative AI and Agentic AI Overview of the Third Edition1. Deepening and Expanding Nature-Related Risk Assessment- For approximately 2,000 NEC Group sites and upstream value chain locations, conducting quantitative analysis of water scarcity and flood/storm risks through collaboration with specialized institutions, and enabling water-related local risk analysis using generative AI and Agentic AI.- Visiting sites located in areas requiring attention and engaging in dialogue with local stakeholders (Practicing the Landscape Approach).- Analyzing the impacts of future natural scenarios on business operations using generative AI.- Organizing the hierarchy of upstream value chain segments (mining, material manufacturing, component manufacturing) and developing future investigation strategies.2. Organizing an Opportunity Framework Leveraging NEC's Strengths- As a part of the client zero approach, integrating generative AI and Agentic AI services into consulting services, and visualizing environmental information in enterprise IT systems.- Introducing five themes that generate value for solving environmental challenges through partnerships with other sectors, leveraging NEC's technologies such as trust technologies and material informatics.Going forward, NEC will incorporate in-depth investigations of supply chain risks into its next mid-term environmental plan, the "Eco Action Plan," starting in 2026, and drive its implementation. Furthermore, insights from the generative AI developed this time will be applied to reporting works under sustainability disclosure standards (SSBJ) and responses to external surveys.NEC will take the lead in tackling various challenges to realize data-driven nature-related management. Through its own practical experience, the company will contribute to customers and society by sharing insights gained through consulting and other services.(*1) Conventionally, local risk assessments have required approximately 40 hours per site. By leveraging Agentic AI, simultaneous assessment of multiple sites can be conducted within about one hour. Utilizing Agentic AI is expected to yield efficiency gains equivalent to approximately 80,000 hours compared to conventional methods for assessing local risks across roughly 2,000 sites.(*2) NEC publishes TNFD Report (2nd Edition)https://www.nec.com/en/press/202407/global_20240729_02.html(*3) Nature Positive Transitions: Sectors: Reports compiled by the World Economic Forum in collaboration with Oliver Wyman that outline actions that each sector should take to transition towards a nature-positive economy. NEC is collaborating with other leading global companies to create the IT sector report.(*4) TNFD Nature Data Public Facility https://tnfd.global/enhancing-market-access-to-global-nature-data/About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Mazda Production and Sales Results for August 2025
HIROSHIMA, Japan, May 29, 2025 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation's production and sales results for August 2025 are summarized below.I. Production BreakdownAugust 2025Jan - Aug 2025UnitsYoYChange (%)UnitsYoYChange (%)DOMESTIC PRODUCTIONPassenger Vehicles48,903+4.3454,694-7.9Total48,903+4.3454,694-7.9 OVERSEAS PRODUCTIONPassenger Vehicles35,851-8.8290,481-1.9Total35,851-8.8290,481-1.9 GLOBAL PRODUCTIONPassenger Vehicles84,754-1.7745,175-5.7Total84,754-1.7745,175-5.71. Domestic ProductionMazda's domestic production volume in August 2025 increased 4.3% year on year due to increased production of passenger vehicles.[Domestic production of key models in August 2025]CX-5:20,457 units(up 43.9% year on year)MAZDA3:8,537 units(up 10.2%)CX-30:8,040 units(up 29.7%)2. Overseas ProductionMazda's overseas production volume in August 2025 decreased 8.8% year on year due to decreased production of passenger vehicles.[Overseas production of key models in August 2025]CX-50:11,337 units(up 1.7% year on year)CX-30:7,918 units(down 25.1%)MAZDA2:6,624 units(up 6.5%)II. Domestic Sales BreakdownAugust 2025Jan - Aug 2025UnitsYoYChange (%)UnitsYoYChange (%)DOMESTIC SALESPassenger Vehicles9,194+0.097,223+16.7Commercial Vehicles732-7.16,592-2.4 Registration Total7,535+3.380,502+24.4Micro-mini Total2,391-10.923,313-8.1Total9,926-0.5103,815+15.2Mazda's domestic sales volume in August 2025 decreased 0.5% year on year due to decreased sales of commercial vehicles.Mazda's market share was 4.0% (up 0.5 points year on year) in the registered vehicle segment, 2.1% in the micro-mini vehicle segment (down 0.1 points), and the total market share was 3.3% (up 0.3 points).[Domestic sales of key models in August 2025]MAZDA2:1,717 units(down 2.1% year on year)CX-5:1,534 units(down 10.3%)MAZDA3:854 units(up 102.4%)III. Exports BreakdownAugust 2025Jan - Aug 2025UnitsYoYChange (%)UnitsYoYChange (%)EXPORTSPassenger Vehicles45,623-7.6384,138-11.3 North America17,042-15.6190,455+1.1Europe13,856+44.175,562-22.5Oceania3,696+6.335,833-12.9Others11,029-31.582,288-22.3Total45,623-7.6384,138-11.3Mazda's export volume in August 2025 decreased 7.6% year on year due to decreased shipments to regions such as North America.[Exports of key models in August 2025]CX-5:20,645 units(up 10.7% year on year)MAZDA3:7,861 units(down 9.3%)CX-30:7,639 units(up 18.4%)IV. Global Sales BreakdownAugust 2025Jan - Aug 2025UnitsYoYChange (%)UnitsYoYChange (%)GLOBAL SALESDomestic Sales9,926-0.5103,815+15.2 U.S.A38,140-7.6293,494+3.5 China5,707+9.543,636-15.6 Europe7,911-22.7101,771-13.3 Others37,179-9.7304,508+4.6Overseas Sales88,937-9.1743,409-0.0Total98,863-8.3847,224+1.6Mazda's global sales volume in August 2025 decreased 8.3% year on year due to decreased sales in markets such as the USA and Europe.[Global sales of key models in August 2025]CX-5:26,335 units(down 14.7% year on year)CX-30:16,195 units(down 13.3%)Mazda3:11,549 units(down 12.2%)*1 Overseas production figures indicate Mazda-brand units coming off the production line (excluding CKD units).*2 Global production figures represent the total sum of domestic and overseas production volumes.*3 All information in this press release is as of the release date. No updates after that date are reflected. Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
DENSO and TUV Rheinland Japan Sign Memorandum of Understanding to Realize Sustainable Product Development and to Promote Digital Product Passport
KARIYA, JAPAN, September 29, 2025 - (JCN Newswire via SeaPRwire.com) - DENSO CORPORATION (Headquarters: Kariya City, Aichi Prefecture; President: Shinnosuke Hayashi, hereinafter referred to as “DENSO”) and TÜV Rheinland Japan, Ltd. (Headquarters: Yokohama City, Kanagawa Prefecture; President: Kunihiro Okamoto, hereinafter referred to as “TÜV Rheinland Japan”) are pleased to announce that DENSO and TÜV Rheinland Japan have signed a memorandum of understanding in order to realize sustainable manufacturing for industrial products, including batteries, and to promote the Digital Product Passport*1 (hereinafter referred to as “DPP”), which contributes to the efforts.In recent years, there has been a strong demand across entire society for achieving carbon neutrality and transitioning to a circular economy that circulates resources within the economic system, therefore it has been accelerating efforts to create sustainable products. As a part of these efforts, the EU implemented the Ecodesign Regulation*2 in July 2024, introducing a new framework that mandates environmental considerations from the design stage of products. Under this regulation, the introduction of the DPP, which electronically records information such as the manufacturer, materials used, CO2 emissions, and recyclability, is required.Furthermore, from February 2027, under the European Battery Regulation*3, the introduction of the “Battery Passport” for battery products, including automotive and industrial batteries, is scheduled to become mandatory as the first use case of the DPP.To support compliance with these regulations, DENSO is developing an application for the Battery Passport and, in February 2025, became the first Japanese company to obtain EcoPass certification from Catena-X*4.In addition, TÜV Rheinland Japan is a third-party certification body that provides testing, certification, inspection, and evaluation services related to product safety and quality, and always offers the latest evaluation services in various industrial fields.DENSO and TÜV Rheinland Japan have now agreed to comprehensively collaborate as strategic partners on verification and certification services for compliance with the Ecodesign Regulation and the European Battery Regulation, as well as on DPP initiatives.Collaboration DetailsThe two companies will cooperate in the development of DPP and related business services, including the Battery Passport.The two companies will collaborate on regulatory compliance and client support related to the Battery Passport.TÜV Rheinland Japan will provide third-party verification and certification services for DENSO's Battery Passport application.The two companies will jointly create technical documentation related to the Battery Passport for clients.Through extensive collaboration, DENSO and TÜV Rheinland Japan will promote DPP initiatives, including the Battery Passport, and contribute to the realization of a sustainable society.Comments from Each CompanyDENSO CORPORATION, Senior Director, Head of Social Innovation Business Development Function Unit, Mitsuru Kato DENSO is committed to traceability and resource circulation throughout the entire product lifecycle. We are very pleased to have established a strategic partnership with TÜV Rheinland Japan, a third-party certification body with extensive experience and expertise, to promote our initiatives related to DPP, which support these efforts. By combining DENSO’s manufacturing expertise and traceability technologies with TÜV Rheinland Japan’s certification and evaluation capabilities, we aim to provide even more reliable products to stakeholders worldwide.TÜV Rheinland Japan Ltd., President, Kunihiro OkamotoTÜV Rheinland Japan provides various testing, certification, and auditing services in accordance with international standards, and has expanded services to support environmentally conscious business operations and sustainable development in recent years. DENSO possesses advanced technologies in the automotive industry, and we expect that this new partnership will open up new possibilities and promote growth for both companies. Together, we will strive for the realization of a sustainable society.Scene from the signing of the memorandum of understandingFrom left to right: Kunihiro Okamoto, President of TÜV Rheinland Japan,and Mitsuru Kato, Senior Director, Head of Social Innovation Business Development Function Unit, DENSO.*1 Digital Product Passport: A digital certificate that records various information to ensure traceability along the product lifecycle, including the manufacturer, materials used, recyclability, and dismantling methods, as proof of the product's sustainability.*2 Ecodesign Regulation: A comprehensive framework that improves environmental performance standards from the design stage for almost all products introduced to the European market, including durability, recyclability, reparability, and energy efficiency, including the DPP. It came into effect in Europe in July 2024.*3 European Battery Regulation: A regulation that sets unified obligations for the design, material procurement, manufacturing, collection, and recycling of batteries to promote the production and use of sustainable and safe battery products. It came into effect in Europe in August 2023, and the application of each requirement has been gradually starting from February 2024.*4 DENSO the First Company Headquartered in Japan to Acquire EcoPass Certification from Catena-X | Newsroom | News | DENSO Global Website Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Sales, Production, and Export Results for August 2025
Toyota City, Japan, September 29, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation announces its sales, production, and export results for August 2025, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd.Click here for detailed sales, production, and export results ("Detailed data (Excel)")Toyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations' Sustainable Development Goals to help realize an ever-better world, where everyone is free to move.SDGs Initiatives: https://global.toyota/en/sustainability/sdgs/ Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
ម៉ាស៊ីនស្វែងរកការងារ CareersElite.com ផ្តល់ជូនការបង្ហោះប្រវត្តិរូបដោយឥតគិតថ្លៃ
(SeaPRwire) - CareersElite.com ក៏ផ្តល់ជូនការប្រកាសការងារក្នុងតម្លៃ 99 ដុល្លារផងដែរNewport Beach, California ថ្ងៃទី 29 ខែកញ្ញា ឆ្នាំ 2025 - CareersElite, គឺជាម៉ាស៊ីនស្វែងរកការងារអន្តរជាតិដែលមានមូលដ្ឋាននៅសហរដ្ឋអាមេរិកដែល "គ្មានការផ្សាយពាណិជ្ជកម្ម" និងជាក្រុមហ៊ុនជ្រើសរើសបុគ្គលិកដោយផ្ទាល់ពី Newport Beach, California, USA។ វេទិកាស្វែងរកការងារថ្មីរបស់យើងផ្តល់ជូននូវជម្រើសដែលគ្មានការផ្សាយពាណិជ្ជកម្មទៅកាន់ម៉ាស៊ីនស្វែងរកការងារបណ្តាញសង្គមដែលរំខានផ្សេងទៀត។ យើងផ្តល់ជូនការបង្ហោះប្រវត្តិរូបសង្ខេបជាទម្រង់អត្ថបទ ឬ Word ដោយឥតគិតថ្លៃ និងការបង្ហោះប្រវត្តិរូបសង្ខេបវីដេអូថ្មីរបស់យើង បូករួមទាំងការដាក់បញ្ចូលទៅក្នុងមុខងារស្វែងរកប្រវត្តិរូបសង្ខេបរបស់យើងដោយឥតគិតថ្លៃ និងការបង្ហោះការងារតម្លៃទាបរបស់យើងគឺ $99 ។ ការរចនាម៉ាស៊ីនស្វែងរកការងារបែបប្រពៃណីរបស់យើងផ្តល់នូវការរំខានតិចជាងមុន ដែលអនុញ្ញាតឱ្យមើលឃើញការបង្ហោះការងាររបស់អ្នកបានប្រសើរជាងមុន ហើយជាមួយនឹងការបង្ហោះការងារតម្លៃ $99 របស់យើង អនុញ្ញាតឱ្យអ្នកបង្ហោះការងារកាន់តែច្រើនក្នុងតម្លៃថោកជាង។ Ellen M. Ward, នាយកប្រតិបត្តិរបស់ CareersElite, Inc., បានថ្លែងថា៖ "យើងបានរកឃើញថា ម៉ាស៊ីនស្វែងរកការងារបណ្តាញសង្គមមួយចំនួនអាចជ្រៀតជ្រែក និងអាចរំខានអ្នកប្រើប្រាស់ពីគោលបំណងចម្បងរបស់ពួកគេគឺការស្វែងរកការងារ។ ជាមួយនឹងការបង្ហោះការងារតម្លៃ 99 ដុល្លាររបស់យើង និយោជកអាចចុះបញ្ជីតំណែងកាន់តែច្រើនក្នុងតម្លៃទាប ដែលនាំឱ្យមានការសន្សំកាន់តែច្រើនសម្រាប់ប្រាក់ចំណេញរបស់ពួកគេ។" មុខងារប្រវត្តិរូបសង្ខេបវីដេអូតែមួយគត់របស់យើងជួយអ្នកស្វែងរកការងារឱ្យលេចធ្លោ។ តាមរយៈការបង្ហាញខ្លួនអ្នកប្រកបដោយវិជ្ជាជីវៈនៅក្នុងវីដេអូសម្ភាសន៍បឋមរយៈពេលមួយនាទីដែលបានថតត្រឹមត្រូវ អ្នកអាចបង្កើតចំណាប់អារម្មណ៍កាន់តែខ្លាំងជាងទម្រង់បណ្តាញសង្គមធម្មតា។ អ្នកនៅតែអាចផ្ទុកឡើងប្រវត្តិរូបសង្ខេបជាអត្ថបទ ឬ Word (CV) ជាមួយ CareersElite។ ការដាក់បញ្ចូលប្រវត្តិរូបសង្ខេបវីដេអូជួយអ្នកឱ្យលេចធ្លោ។ ប្រវត្តិរូបសង្ខេបវីដេអូអនុញ្ញាតឱ្យក្រុមហ៊ុនត្រួតពិនិត្យបេក្ខជនជាមុនប្រកបដោយប្រសិទ្ធភាព ដោយសន្សំពេលវេលា និងធនធាន មុនពេលបន្តទៅការសម្ភាសន៍។ "ម៉ាស៊ីនស្វែងរកការងារ" គ្រាន់តែជាផ្នែកមួយនៃសេវាកម្មជាច្រើនរបស់ CareersElite ប៉ុណ្ណោះ។ សេវាកម្មសំខាន់មួយរបស់ CareersElite គឺការទំនាក់ទំនងយ៉ាងឆាប់រហ័ស និងបន្តជាមួយអតិថិជន។ អត្រាការជ្រើសរើសបុគ្គលិករបស់យើងគឺជាផ្នែកមួយក្នុងចំណោមអត្រាទាបបំផុតនៅក្នុងឧស្សាហកម្មនេះ ពោលគឺ 12% នៃប្រាក់ខែប្រចាំឆ្នាំ បើប្រៀបធៀបទៅនឹង 20% + សម្រាប់ភ្នាក់ងារជ្រើសរើសបុគ្គលិកភាគច្រើនផ្សេងទៀត។ យើងបង្ហោះការងាររបស់អ្នកសម្រាប់អ្នក ហើយយើងផ្តល់ការធានាផ្លាស់ប្តូររយៈពេល 30 ថ្ងៃ។ (លក្ខខណ្ឌត្រូវបានអនុវត្ត) ដើម្បីស្វែងយល់បន្ថែមអំពី CareersElite សូមចូលទៅកាន់ CareersElite.com () ឬទាក់ទងមកយើងតាមរយៈ . សូមទស្សនាពួកយើងនៅលើគេហទំព័រនៅ .ទំនាក់ទំនងប្រព័ន្ធផ្សព្វផ្សាយCareersElite, Inc.9493875366PO box 10712 ប្រភព :CareersElite, Inc. អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។
Isuzu and Toyota to Jointly Develop Next-Generation Fuel Cell Route Bus
TOKYO, Japan, September 29, 2025 - (JCN Newswire via SeaPRwire.com) - Isuzu Motors Limited (Isuzu) and Toyota Motor Corporation (Toyota) announced today an agreement to jointly develop next-generation fuel cell (FC) route buses for commercialization. Production is scheduled to begin in fiscal year 2026 (April 2026-March 2027) at the Utsunomiya Plant (Utsunomiya City, Tochigi Prefecture) of J-Bus, Ltd. (J-Bus), an equal joint venture between Isuzu and Hino Motors, Ltd. (Hino).The vehicle will be based on the flat-floor battery electric route bus platform planned, developed, and designed by Isuzu and manufactured by J-Bus. Isuzu and Hino-who have been collaborating in the bus segment since 2002-launched this platform in fiscal year 2024. It will be combined with an FC system developed by Toyota. As part of their efforts to realize zero-emission vehicles, Isuzu and Toyota are jointly developing the next-generation FC bus, seeking to reduce costs by standardizing BEV and FCEV parts.Expanding the range of carbon neutral options beyond battery electric buses, Isuzu is working to commercialize the next-generation FC route bus as a new technology. Toyota positions hydrogen as an important energy source in the pursuit of carbon neutrality and is advancing various initiatives in producing, transporting, storing, and using hydrogen in collaboration with a wide range of partners across industries. Together, the two companies will work with local governments and businesses in various regions-including those designated by the Ministry of Economy, Trade and Industry in May 2025 as Priority Regions for Promoting the Deployment of Fuel-Cell Commercial Vehicles - to contribute to the steady reduction of CO2 emissions by expanding the use of next-generation FC route buses."Achieving zero, and adding new value beyond it"As part of efforts to pass our beautiful "Home Planet" to the next generation, Toyota has identified and is helping to solve issues faced by individuals and overall society, which Toyota calls "Achieving Zero," hoping to help reduce the negative impacts caused by these issues to people and the environment to zero. Additionally, Toyota is also looking "Beyond Zero" to create and provide greater value by continuing to diligently seek ways to improve lives and society for the future.About Beyond Zero: https://global.toyota/en/mobility/beyond-zero/Toyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations' Sustainable Development Goals to help realize an ever-better world, where everyone is free to move.SDGs Initiatives: https://global.toyota/en/sustainability/sdgs/ Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
31 Concept Accelerates Next-Gen DPI Leadership With Strategic Acquisition of Xynthor AI
DUBAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - 31 CONCEPT (31C), a leading UAE-based cybersecurity innovator, today announced the strategic acquisition of Xynthor AI Software Inc., a Canadian company pioneering AI-native Data Loss Prevention (DLP) solutions. This acquisition strengthens 31C's commitment to advancing Deep Packet Intelligence (DPI), corporate security, and data sovereignty in an AI-centric world.31 Concept & XynthorBy integrating Xynthor's "DLP for AI Era" with 31C's DPI expertise, the combined platform will deliver the most comprehensive AI-aware security solution available. This move addresses the growing need for security systems capable of handling modern AI-driven workflows.Why It MattersThe rise of generative AI tools such as ChatGPT and Claude has outpaced the capabilities of traditional DLP systems, which were built for structured data and static rules. High-profile incidents, including the accidental leakage of proprietary source code by Samsung engineers using ChatGPT, highlight the urgent need for AI-specific safeguards.Misha Hanin, CEO of 31C, emphasized: "The convergence of AI and cybersecurity is the most significant paradigm shift our industry has ever seen. Traditional methods cannot manage the dynamic, context-aware data flows of today's AI environments. Through this acquisition, we are pioneering an entirely new category of AI-native security solutions."Xynthor's Breakthrough TechnologyXynthor brings several unique differentiators:AI Data Guardian: Prevents sensitive information from leaving the organization using NLP-driven detection.Air-Gapped Architecture: Keeps analysis inside the client's environment, ensuring privacy and compliance.Context-Aware Intelligence: Reduces false positives through AI-driven classification and behavioral analysis.Private LLM Protection: Enables safe use of internal large language models without external exposure.Seamless Integration: Works with existing infrastructure while supporting regulations like HIPAA and GDPR.Comprehensive AI-Era PlatformThe integrated platform enhances DPI with real-time policy management, adaptive threat detection, and behavioral analytics. It also streamlines compliance with GDPR, HIPAA, PCI DSS, and upcoming AI governance standards.Boris Heismann, CTO of 31C, stated: "We're not only responding to current demands but anticipating tomorrow's challenges. Combining DPI with AI-native DLP creates a future-ready security platform."Strategic ImpactThe global cost of data breaches averages over $4 million per incident, and AI-driven risks are only increasing. By uniting DPI and AI-native DLP, 31C positions itself as a global leader capable of addressing these critical challenges.This acquisition aligns with 31C's growth strategy, including performance-based incentives tied to Xynthor's product success. Both companies will continue to operate from the UAE and Canada, combining their strengths to accelerate innovation and market expansion.About 31CFounded in the UAE, 31C is a cybersecurity company specializing in Deep Packet Intelligence, corporate security, and data sovereignty. Its innovative approach makes it a trusted partner for enterprises, governments, and regulators worldwide.About Xynthor AIBased in Canada, Xynthor AI develops AI-native security platforms designed to protect organizations using generative AI, ensuring both safety and compliance in the AI era.For more information about 31C's Next Gen DPI solutions, visit https://31c.io.Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 Concept Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Fujitsu and AIST sign collaboration agreement to strengthen international industrial competitiveness in quantum technology
Kawasaki and Tsukuba, Japan, September 29, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and the Global Research and Development Center for Business by Quantum-AI technology (G-QuAT) at the National Institute of Advanced Industrial Science and Technology (AIST) today announced the signing of a collaboration agreement to strengthen international industrial competitiveness in quantum technology. The agreement, signed on September 26, 2025, aims to enhance cooperation between the two organizations, thereby boosting Japan's standing globally in this sector.As part of the agreement, Fujitsu and G-QuAT will leverage their combined resources, including quantum computer-related technologies, manufacturing and evaluation facilities, and will promote research and development and personnel exchange. In this way, the partnership aims to foster international collaboration and research cooperation, ultimately contributing to sustainable economic growth.Scaling up quantum computers requires the integration of diverse elemental technologies and the comprehensive verification and optimization of the entire quantum computer system. To address this challenge, the two organizations will promote research cooperation, including the development of supporting environments and demonstration of technologies necessary for large-scale superconducting quantum computers, maximizing the use of G-QuAT's facilities and its hub function for international collaboration. Through this initiative, the partners aim to establish the superiority of Japan's quantum computing technology, including that of component manufacturers, and actively promote it globally to foster expansion into the international market.Photo of MASU Kazuya, G-QuAT Director (right) and Vivek Mahajan, Corporate Executive Officer, Corporate Vice President, CTO, in charge of System Platform, Fujitsu Limited (left) signing ceremonyAbout FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuAbout National Institute of Advanced Industrial Science and Technology (AIST) The National Institute of Advanced Industrial Science and Technology (AIST), one of the largest public research organizations in Japan, focuses on the creation and practical realization of technologies useful to Japanese industry and society, and on “bridging” the gap between innovative technological seeds and commercialization. Global Research and Development Center for Business by Quantum-AI technology (G-QuAT), established in 2023, promotes the social implementation of advanced convergence computational technology and aims to build a global business ecosystem to solve economic and social issues, create new markets, and pioneer aftermarkets from the benefits. Find out more: G-QuATPress ContactsFujitsu LimitedInquiriesGlobal Research and Development Center for Business by Quantum-AI technology (G-QuAT)E-mail: M-G-QuAT-plan-ml*aist.go.jp (Please convert "*" to "@".) Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
World’s First Methanol Dual-Fuel PCTC ‘CM HONG KONG’ makes its maiden voyage to Hong Kong
HONG KONG, Sep 29, 2025 - 28 September, The world's first 9,300 CEU methanol dual-fuel Pure Car and Truck Carrier (PCTC), "CM HONG KONG", celebrated its maiden voyage with a ceremony in Tsing Yi, Hong Kong. Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, Deputy Director of the Liaison Office of the Central People's Government in the HKSAR, Qi Bin, and Chairman of China Merchants Group Limited, Miao Jianmin, etc. attended the ceremony, with Executive Vice President of China Merchants Group Limited, Deng Renjie, as the master of ceremonies.During the event, a commemorative plaque was presented to the ship's captain. Guests toured the vessel's bridge, crew quarters, and innovative methanol dual-fuel system, witnessing its advancements in low-carbon technology and operational efficiency.Built for China Merchants Energy Shipping (CMES), "CM HONG KONG" is the first large-scale car carrier powered by a methanol dual-fuel system, enabling seamless switching between conventional fuel and methanol. Compliant with IMO Tier III emission standards, it achieves over 70% emissions reduction when using green methanol. The ship, measuring 219.9 meters long and 37.7 meters wide, has a design capacity of 9,300 CEUs, with an actual capacity of up to 9,492 CEUs. Its 78,416-square-meter loading area, equivalent to 11 football fields, features 13 decks, including three adjustable lift decks and three tailored for hydrogen fuel cell vehicles. Dual stern and side ramps boost loading/unloading efficiency by 30%. Safety is enhanced with 156 CCTV cameras and thermal imaging infrared sensors across all decks."CM HONG KONG" embarked on its inaugural China-to-Europe route, unloading vehicles in Hong Kong before heading to Europe. Leveraging Hong Kong's free port status, CMES aims to advance the "green fuel trade + port services" model, fostering economic growth, attracting international vessels for green fuel bunkering, and strengthening Hong Kong's role as a global green maritime hub.Vice-chairperson of the National Committee of the Chinese People's Political Consultative Conference, Leung Chun-ying, delivered a speech at the ceremony.Chief Secretary for Administration of the HKSAR, Chan Kwok-kei, delivered a speech at the ceremony.Chairman of China Merchants Group Limited, Miao Jianmin, delivered a speech at the ceremony. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
World Quantum Summit 2025 Concludes to a Full House: “Quantum Unboxed” Signals the Next Leap in AI and Industry Transformation
SINGAPORE, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - The future arrived today in Singapore as the World Quantum Summit 2025 (WQS) — themed “Quantum Unboxed: Extending the Reach of AI” — concluded at the Sheraton Towers Singapore with a full house attendance filling the ballroom to capacity. The overwhelming turnoutunderscored the growing global appetite for practical quantum solutions that extend the power of artificial intelligence and accelerate its real-world impact.This year’s summit was not a standalone event but the culmination of a three-day intensive journey into the future of computing and intelligence. On 23–24 September, participants took part in a sold-out Executive Workshop on Quantum and AI, which built foundational understanding of quantum principles, emerging architectures, and integration strategies. The final day brought it all together, showcasing how those concepts are now being deployed in industry — from real-world applications to large-scale investment strategies.Unlike traditional conferences focused solely on research or theory, WQS 2025 brought together the entire ecosystem driving quantum innovation forward. The summit featured practitioners representing different quantum approaches, policy makers, venture investors, academics, corporates, researchers, and ecosystem partners — all converging under one roof to chart the path from lab breakthroughs to industry-scale adoption. On the exhibition floor, leading players such as ST Engineering, QBoson, and TM Research & Development showcased quantum - enhanced solutions in optimisation, secure computing, and AI acceleration. Meanwhile, Gold Capital Network Partners — IMGT and IWC Management — hosted curated sessions connecting founders and investors to accelerate funding into quantum ventures poised for growth.A key highlight was the line-up of 19 world-class speakers, each offering cutting-edge insights into how quantum is transforming the AI landscape. Among them were Assoc. Prof. Mile Gu, Deputy Director of the Nanyang Quantum Hub at Nanyang Technological University; Jeremy Woo, Senior Technical Advisor at D-Wave System; Deepak Waghmare, CTO (APJC) of Dell Technologies; Ujjwal Kumar, Principal Architect, Office of the CTO at Microsoft Asia; Dr. Simon See, Senior Director and Global Head of the NVIDIA AI Technology Center; Bruno Aznar Martinez, R&D Software Developer at Keysight Technologies; Raghunath Koduvayur, CEO of RAQS Quantum; Gao Qi, Algorithm Director at QBoson; Ken Chew, CEO and Partner of IWC Management; and Tony Gu, General Partner at NGC Ventures. They were joined by Ong Yongcheng of Insignia Ventures, Dr. Amelia Tan of ST Engineering, Eric Lee of Deloitte Southeast Asia, Atsushi Sugiura of Oxford Quantum Circuits, Hidetoshi Matsumura of Fujitsu Limited, Ray Han of SAP, Duleesha Kulasooriya of Deloitte, Manisha Sharma Kohli of Google, and Simon Lawrie of AWS.Throughout the summit, a clear narrative emerged: quantum computing has moved beyond theory into strategic deployment, offering a powerful multiplier for AI. Industry leaders showcased case studies where quantum-enhanced AI is already delivering breakthrough results — from accelerating molecular simulations and optimising financial portfolios to solving supply chainchallenges previously considered intractable. Discussions highlighted how enterprises are integrating quantum capabilities directly into their AI workflows, achieving dramatic improvements in processing power, speed, efficiency, and cost-to-insight.The summit also reflected the shifting investment landscape. As quantum technologies mature, institutional and venture capital investors are moving rapidly to back companies with commercially viable products and near-term revenue potential. “Quantum is no longer the future — it’s today’s most powerful strategic edge and already seeing some real applications,” said Ken Chew, CEO of IWC Management. “The confluence of quantum and AI and their cross-synergies are powerful and those who integrate it into their AI stack early will potentially define the competitive landscape of the next decade.”By the close of the event, one message was clear: quantum will not replace AI — it will supercharge it. With practitioners, investors, policymakers, and researchers now aligned on the urgency of adoption, the era of practical quantum applications is no longer a distant vision — it is here, and it is redefining howindustries think about computation, intelligence, and innovation.The World Quantum Summit has firmly established itself as Asia’s premier platform for quantum commercialisation, bridging science, industry, and capital to accelerate real-world adoption. With its unique focus on applications over abstraction and its ability to convene the full quantum ecosystem, WQS is not just a conference — it is a catalyst for the next wave of technological transformation.Media Contact:Eric KhooConference Director, TPGI Pte Ltderic.khoo@pinnaclegroup.global+65 8383 2480 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Hua Medicine Announces that the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin
Hong Kong Department of Health accepts NDA for dorzagliatin, the world’s first approved glucokinase activator (GKA).Builds on China approval and strong Phase III and real-world clinical results showing durable glucose control and safety.Positions Hong Kong as a strategic gateway for Hua Medicine’s global expansion into Southeast Asia and beyond.SHANGHAI, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (“the Company”, HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative Region of China accepted a New Drug Application (NDA) for dorzagliatin, the world’s first glucokinase activator (GKA) approved for the treatment of Type 2 diabetes (T2D).The acceptance of the NDA marks an important milestone in Hua Medicine’s strategy to expand beyond China, bringing its innovative, disease-modifying treatment to more patients across Asia and ultimately to global markets.With more than half a million people living with diabetes in Hong Kong and nearly 240 million across Asia, the NDA represents a significant step toward addressing one of the region’s most urgent health challenges.A first-in-class therapy with global potentialDorzagliatin was approved for marketing by the China National Medical Products Administration (NMPA) in September 2022 for two indications, both to improve blood glucose control for T2D patients, 1) It can be used as mono-treatment for drug-naïve T2D patients, as first-line treatment, 2) When metformin hydrochloride alone has poor blood glucose control, it can be used in combination with metformin hydrochloride. Unlike conventional drugs that manage symptoms, dorzagliatin targets the root cause of blood sugar dysregulation by repairing the function of glucokinase (GK), the body’s glucose sensor. By restoring glucose sensitivity, dorzagliatin helps maintain blood sugar balance and supports long-term disease management.Results from two Phase III registration trials in China demonstrated that dorzagliatin significantly and sustainably lowered HbA1c levels, improved pancreatic β-cell function, and reduced insulin resistance, all while showing strong safety and tolerability. Findings are being further validated in ongoing real-world studies, of which some interim analysis and data were presented at the 2025 American Diabetes Association (ADA) Scientific Sessions.Strategic gateway to new marketsHong Kong has established a comprehensive, community-based system for diabetes management and serves as a medical and financial hub for the region. Research findings from the Hong Kong Diabetes and Obesity Research Institute at The Chinese University of Hong Kong indicate that the implementation of a community-based public-private collaboration model for diabetes management provided significant benefits to the community. The advanced experience in Hong Kong is of great significance for improving the quality of life of diabetes patients, controlling the progression of the disease, and reducing the burden on the healthcare system. Once approved in Hong Kong, it will also provide clinical application of dorzagliation for the personalized management of diabetes.According to Hong Kong's former new drug approval mechanism, applicants were required to submit to the authority new drug registration certificates issued by the drug regulatory agencies of two or more recognized countries, as well as other specified relevant documents, in order to support the approval and marketing of the product. Under the newly established "1+" mechanism, after meeting requirements such as local clinical data support and having the applicable scope of the new drug endorsed by local experts, an applicant only needs to submit the approval from one (instead of the original two) reference drug regulatory authority to apply for registration of the new drug in Hong Kong. This mechanism initially applied to new drugs for the treatment of serious or rare diseases, and has been extended to all new drugs since 2024.Under the leadership of Ms. Beili Cao, Vice President of Department of Corporate Operation and Great Bay Development, Hua Medicine has conducted sufficient and in-depth communications with local clinical experts and regulatory authorities in Hong Kong, and became an early pioneer of this mechanism. The Company filed its application for registration of dorzagliatin in Hong Kong at the end of July, and the application was officially accepted by the end of September.Dr. Li Chen, Founder and Chief Executive Officer of Hua Medicine, said: “Acceptance of dorzagliatin’s NDA in Hong Kong is not only recognition of its clinical value but also a pivotal step in Hua Medicine’s international journey. Hong Kong’s unique position as a regional healthcare leader and financial hub makes it the ideal gateway for expanding dorzagliatin’s reach into Southeast Asia and beyond. We are committed to working with local doctors and partners in Hong Kong to explore dorzagliatin’s potential in both treatment and prevention of prediabetes and early-stage diabetes, ensuring more patients worldwide can benefit from this breakthrough therapy.”Dorzagliatin: A transformative T2D treatmentDorzagliatin was approved in September 2022 in China, and it was included in the country’s National Reimbursement Drug List (NRDL) as of January 1, 2024.Dorzagliatin can be used alone as a first-line therapy for newly diagnosed patients, or together with metformin when blood sugar control is inadequate. Unlike many other approved oral antidiabetes drugs, no dose adjustment is required for patients with kidney impairment. It works by repairing the body’s glucose sensor, glucokinase (GK), restoring glucose sensitivity and long-term blood sugar balance. It acts across key organs—stimulating insulin secretion in the pancreas, boosting GLP-1 secretion in the gut, and regulating glycogen in the liver. This multi-target approach addresses the root cause of Type 2 diabetes, not just its symptoms.The NDA application in Hong Kong is based on the results of two Phase III registration clinical studies conducted in China evaluating the use of dorzagliatin monotherapy and in combination with metformin for the treatment of patients with Type 2 diabetes. Two studies have shown that for two categories of T2D patients—those newly diagnosed and not yet on medication, and those who have failed to respond adequately to metformin therapy— dorzagliatin can sustainably and effectively lower patients' HbA1c levels by repairing defects in the glucose sensor function of GK, significantly reduce postprandial two-hour blood glucose levels (2h-PPG), achieve high glycemic control rates without hypoglycemia, demonstrate good safety and tolerability, and continuously improve β-cell function and reduce insulin resistance.Forward-Looking StatementsThis document contains statements regarding Hua Medicine’s future expectations, plans, and prospects for the Company and its products. These forward-looking statements pertain only to events or information as of the date they are made and may change due to future developments. Unless required by law, we are not obligated to update or publicly revise any forward-looking statements or unexpected events after the date of such statements, regardless of new information, future events, or other circumstances. Please read this document carefully and understand that our actual future performance or results may differ materially from expectations due to various risks, uncertainties, or other legal requirements.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsWebsite: ir@huamedicine.comMediaWebsite: pr@huamedicine.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
តើ Task ភាគទី 4 បង្កើនការប្រថុយប្រថានយ៉ាងឃោរឃៅនៃរឿងភាគឧក្រិដ្ឋកម្ម HBO យ៉ាងដូចម្ដេច
(SeaPRwire) - ការព្រមាន៖ អត្ថបទនេះមានការបញ្ចេញSpoiler សម្រាប់វគ្គទី 4 នៃ ។ នៅពេលដែលវគ្គសប្តាហ៍នេះនៃ ឈានដល់ទីបញ្ចប់ដ៏គួរឱ្យសោកសៅ គេមិនអាចបដិសេធបានទេថាកំពែងហាក់ដូចជាកំពុងតែបិទ Robbie (Tom Pelphrey) ជិតហើយ។ ប៉ុន្តែដោយសារនៅសល់វគ្គចំនួន 3 ទៀតនៃរឿងភាគឧក្រិដ្ឋកម្ម HBO ទៅទៀត ដូច្នេះយើងត្រូវសន្មតថាអ្វីៗនឹងមិនប្រព្រឹត្តទៅដូចដែលពួកគេកំពុងគិតនៅពេលនេះនោះទេ។ បន្ទាប់ពីការផ្លាស់ប្តូរនុយដែលបណ្តាលឱ្យ Cliff (Raúl Castillo) ត្រូវបានចាប់ខ្លួន និងធ្វើទារុណកម្មរហូតដល់ស្លាប់ដោយ Jayson (Sam Keeley) និងក្រុម Dark Hearts របស់គាត់ Perry (Jamie McShane) បានចាប់ផ្តើមធ្វើការដើម្បីកំណត់អត្តសញ្ញាណម្ចាស់ដើមនៃកាំភ្លើងដែលពួកគេបានរកឃើញនៅក្នុងឡានរបស់ Cliff បន្ទាប់ពី Jayson បានបើកឡានទម្លាក់គាត់ទៅចិញ្ចើមផ្លូវ ខណៈពេលដែលគាត់កំពុងរង់ចាំធ្វើកិច្ចព្រមព្រៀងគ្រឿងញៀន។ ចាប់តាំងពីបានដឹងថាកាំភ្លើងដែលបានសម្លាប់សមាជិក Dark Hearts លោក Warren Clarke (Joshua Dye) នៅក្នុងការប្លន់ផ្ទះអន្ទាក់ដែលខុសប្រក្រតី ធ្លាប់ជារបស់សមាជិកម្នាក់របស់ពួកគេ Perry បានបន្តបេសកកម្មដើម្បីរកឱ្យឃើញថាតើនរណានៅខាងក្នុងក្រុមអ្នកជិះម៉ូតូដែលកំពុងផ្តល់ព័ត៌មានដល់ចោរ។ ហើយការស្រាវជ្រាវរបស់គាត់បានទទួលផ្លែផ្កា នៅពេលដែលពេលវេលាបិទវគ្គបានបង្ហាញគាត់ផ្គូផ្គងស្រោមដាក់កាំភ្លើងទៅនឹងរូបថតចាស់របស់បងប្រុសដែលបានស្លាប់របស់ Robby គឺ Billy (Jack Kesy) ពាក់ស្រោមដូចគ្នា។ ជាអកុសល ការផ្តោតអារម្មណ៍របស់គាត់បានប្តូរទៅមនុស្សម្នាក់ទៀតនៅក្នុងរូបភាពនោះវិញគឺ កូនស្រីរបស់ Billy ឈ្មោះ Maeve (Emilia Jones)។ ក្នុងរយៈពេលប៉ុន្មានម៉ោងមុនពេល Robbie និង Cliff បរាជ័យក្នុងការណាត់ជួបជាមួយអ្នកដែលសន្មតថាជាអ្នកផ្គត់ផ្គង់គ្រឿងញៀនរបស់ Ray (Peter Patrikios) ដែលជាអតីតមិត្តរួមបន្ទប់របស់ Cliff នោះ Maeve បានផ្តល់ឱសានវាទដល់ Robbie ថាប្រសិនបើគាត់មិនប្រគល់ Sam (Ben Lewis Doherty) ទៅឱ្យប៉ូលីសនៅព្រឹកបន្ទាប់ទេ នាងនឹងធ្វើវាដោយខ្លួនឯង។ ប៉ុន្តែចុះយ៉ាងណាបើទង្វើល្អដែលចង់ធ្វើនោះ នាំឱ្យនាងធ្លាក់ចូលក្នុងកណ្តាប់ដៃសងសឹករបស់ Perry និង Dark Hearts កាន់តែខ្លាំងទៅទៀត? អ្វីៗទាំងអស់នេះហាក់ដូចជាអាក្រក់សម្រាប់ Eryn (Margarita Levieva) ផងដែរ ដែល Perry បានចោទប្រកាន់រួចហើយថាជាអ្នកក្បត់របស់ក្រុម បន្ទាប់ពីបានដឹងថា Jayson កុហកអំពី Billy លួចពី Dark Hearts ជាលេសសម្រាប់ការវាយគាត់រហូតដល់ស្លាប់ដោយសារតែទំនាក់ទំនងស្នេហារបស់ Eryn ជាមួយគាត់។ អ្វីដែលមិនបានជួយនោះគឺថា Eryn ពិតជាអ្នកដែលប្រាប់ Robbie និង Cliff ថាតើផ្ទះណាខ្លះដែលត្រូវវាយប្រហារ។ ការស្មានរបស់យើងគឺថាការផ្តល់ជូនរបស់ Perry ក្នុងការលាក់ Eryn និងកូនៗរបស់នាងនៅកន្លែងណាមួយដែល Jayson មិនអាចរកឃើញពួកគេ មិនមែនពិតជាត្រឹមត្រូវនោះទេ។ McShane បាននិយាយកាលពីសប្តាហ៍មុននៅក្នុងការវិភាគ "Inside Episode 3" របស់ HBO ថា "Perry មិនខ្វល់ពីអ្វីដែលកំពុងកើតឡើងនៅក្រោមការឃ្លាំមើលរបស់គាត់ទេ។ គាត់ចាប់អារម្មណ៍នឹងអ្វីដែលកំពុងកើតឡើង។ ខ្ញុំគិតថាគាត់គ្រាន់តែមានអារម្មណ៍ថា អូខេ អ្វីមួយបានកើតឡើង។ អ្វីមួយខុសប្រក្រតីដូចដែលរឿងរ៉ាវកើតឡើង។ ហេតុអ្វីបានជាវាកើតឡើង? តើនរណាជាអ្នកបង្កហេតុ? តើយើងត្រូវធ្វើអ្វីខ្លះ? តើយើងជួសជុលវាយ៉ាងដូចម្តេច? ប៊ូម នោះហើយជាវា។ ប៉ុន្តែវាក៏មានការអាណិតអាសូរផងដែរថាតើនរណាជាអ្នកចូលរួមនៅក្នុងអ្វីៗទាំងអស់នោះ និងអ្វីដែលជាផលវិបាកនៃរឿងនោះ [គឺ]។" ខណៈពេលដែល Cliff បដិសេធមិនប្រគល់ឈ្មោះរបស់ Robbie ទោះបីជាបច្ចេកទេសសួរចម្លើយដែលមិនសូវរីករាយរបស់ Dark Hearts ក៏ដោយ ប្រសិនបើ Perry ជ្រើសរើសដេញតាម Eryn ឬ Maeve នោះ ទំនងជាគាត់នឹងរកឃើញតួនាទីរបស់ Robbie នៅក្នុងរឿងទាំងមូលនៅទីបំផុត។ ហើយនៅពេលដែលរឿងនោះកើតឡើង Robbie ល្អជាងត្រូវប្រាកដថាកូនៗរបស់គាត់នៅឆ្ងាយពីគ្រោះថ្នាក់។ ក៏មានសំណួរអំពីអ្នកលបចូលនៅក្នុង FBI ផងដែរ ដែលកម្មវិធីនេះហាក់ដូចជាកំពុងដឹកនាំយើងឱ្យជឿថាពិតជា Kathleen McGinty (Martha Plimpton) ជាជាងសមាជិកកងកម្លាំងការងារទាំងបីដែលកំពុងធ្វើការក្រោម Tom (Mark Ruffalo)។ មិនត្រឹមតែយើងបានឃើញនាងធ្វើការហៅទូរស័ព្ទដ៏ចម្លែកនោះទេ "យើងអាចមានបញ្ហា" បន្ទាប់ពីប្រាប់ Tom ឱ្យផ្តោតលើរាត្រីខាងមុខជាជាងការលេចធ្លាយនោះទេ ប៉ុន្តែកាមេរ៉ាក៏បានផ្តោតលើនាងនៅផ្ទៃខាងក្រោយនៃរូបភាពដែលបង្ហាញពីការខកចិត្តរបស់ Tom ចំពោះការពិតដែលប្រតិបត្តិការបង្ក្រាបរបស់ FBI បានកើតឡើងនៅទីតាំងខុស។ តើអ្នកកំពុងធ្វើអ្វី Kathleen? ឬតើអ្នកគ្រាន់តែជាត្រីក្រហមមួយទៀត? ជាសំណាងល្អ—ឬគួរឱ្យស្តាយអាស្រ័យលើអ្នកដែលអ្នកកំពុងគាំទ្រ—នៅពេលដែលអ្វីៗហាក់ដូចជាកំពុងដំណើរការប្រឆាំងនឹង Tom គាត់បានទទួលព័ត៌មានថ្មីដ៏ធំមួយនៅក្នុងទម្រង់ជារូបថតរបស់ Sam ដែលថតនៅលើ iPhone របស់ពលរដ្ឋដែលព្រួយបារម្ភដែល Robbie បានវាយដំកាលពីដើមថ្ងៃនោះ។ Robbie ក៏មាននៅក្នុងរូបថតនោះដែរ ទោះបីជាដៃរបស់គាត់បាំងមុខភាគច្រើនក៏ដោយ។ ប៉ុន្តែប្រសិនបើ Tom ក៏មានឱកាសនិយាយជាមួយជនរងគ្រោះនៃការវាយប្រហាររបស់ Robbie ដែរ នោះហាក់ដូចជាគាត់នឹងមានព័ត៌មានគ្រប់គ្រាន់ដើម្បីចាប់ផ្តើមផ្តោតលើគាត់។ ប្រហែលជារឿងនេះនឹងលាតត្រដាងនៅពេលដែល Robbie ដឹងពីជោគវាសនារបស់មិត្តល្អបំផុតរបស់គាត់ និងតស៊ូជាមួយនឹងការពិតដែលថាមផែនការរបស់ពួកគេក្នុងការរត់គេចទៅប្រទេសកាណាដាត្រូវបានរារាំង—លុះត្រាតែគាត់ចង់ទៅតែម្នាក់ឯង។ ទន្ទឹមនឹងនេះ យើងបានឃើញ Emily សរសេរសេចក្តីថ្លែងការណ៍អំពីផលប៉ះពាល់របស់ជនរងគ្រោះសម្រាប់ការកាត់ទោសប្អូនប្រុសរបស់នាងឈ្មោះ Ethan និងចាប់ផ្តើមដួលរលំនៅក្រោមទម្ងន់នៃស្ថានភាពគ្រួសារដែលមិនអាចទៅរួចរបស់នាង។ តើនាងនឹងនៅខាងប្អូនប្រុសរបស់នាងលើសពីគ្រួសារចិញ្ចឹមរបស់ពួកគេ ដោយបោះជីវិតគ្រួសាររបស់ Tom ទៅក្នុងភាពវឹកវរ ខណៈពេលដែលការស៊ើបអង្កេតឈានដល់ចំណុចកំពូល? អត្ថបទនេះត្រូវបានផ្តល់ជូនដោយអ្នកផ្គត់ផ្គង់មាតិកាដែលទីបញ្ចូល។ SeaPRwire (https://www.seaprwire.com/) មិនមានការធានា ឬ បញ្ចេញកំណត់ណាមួយ។ ប្រភេទ: ព័ត៌មានប្រចាំថ្ងៃ, ព័ត៌មានសំខាន់ SeaPRwire ផ្តល់សេវាកម្មផ្សាយពាណិជ្ជកម្មសារព័ត៌មានសកលសម្រាប់ក្រុមហ៊ុន និងស្ថាប័ន ដែលមានការចូលដំណើរការនៅលើបណ្ដាញមេឌៀជាង 6,500 បណ្ដាញ ប័ណ្ណប្រតិភូ 86,000 និងអ្នកសារព័ត៌មានជាង 350 លាន។ SeaPRwire គាំទ្រការផ្សាយពាណិជ្ជកម្មជាសារព័ត៌មានជាភាសាអង់គ្លេស ជប៉ុន ហ្រ្វាំង គូរី ហ្វ្រេនច រ៉ុស អ៊ីនដូនេស៊ី ម៉ាឡេស៊ី វៀតណាម ចិន និងភាសាផ្សេងទៀត។ ```
Quantum Solutions to Soar Past 100,000 ETH as Landmark Investment from SIG x ARK x IAM Crowns Japan’s ETH Champion
TOKYO, Sep 29, 2025 - (ACN Newswire via SeaPRwire.com) – Quantum Solutions Co., Ltd. (Tokyo Stock Exchange Code: 2338.T, “Quantum”) announced its strategic financing initiative on September 26 to issue 44 million shares to a blue-chip investor mix of three heavyweight institutions, providing the necessary permanent capital and network access to position Quantum as a potential frontrunner in the world of Ethereum (ETH) listed strategies and a showcase standout in the Tokyo stock market.For Japanese investors, this represents another significant commitment by leading US capital, following Warren Buffett’s investment in Japan’s five major trading companies. For international investors, it signals that Tokyo’s stock market is an increasingly attractive destination for global capital, welcoming new opportunities for “smart money”.Dream Team of Global Capital Aligns for Quantum, International Demand for Japanese Equities Continues to GrowQuantum’s investor line-up is a market stunner in the emerging field of crypto-linked equities. Susquehanna International Group (SIG), investing via CVI Investments, holds the capital firepower to accelerate Quantum’s ETH accumulation and expand its balance sheet for upcoming fundraising rounds. With a portfolio that includes early investments in ByteDance and Strategy Inc. (NASDAQ: MSTR), SIG is a Tokyo Stock Exchange participant, offering the robust capital infrastructure that analysts consider essential for a successful Digital Asset Treasury (DAT).Cathie Wood affirms her position as the world’s leading investor in crypto-linked equities with ARK Invest’s first direct foray into APAC-listed opportunities. In the US market, ARK has a track record for identifying category leaders such as ETH Treasury Bitmine Immersion Technologies (NYSE: BMNR) and cryptocurrency exchange Coinbase (NASDAQ: COIN). By adding Quantum, Wood extends her expertise to the Tokyo market, bringing visibility to Quantum in front of the global investing audience as the region’s most promising ETH Treasury initiative.The third participant is Hong Kong-based Integrated Asset Management (IAM), led by Mr. TC Yam. As the majority shareholder of Forbes Media, IAM’s cross-sector presence in international finance and media resources bolsters Quantum’s capital depth and reputational standing. Like ARK, IAM makes its first public investment in the Tokyo stock market, signaling growing confidence among global institutional investors in Japan's equity market.The fundraise utilizes convertible bonds and both floating and fixed strike price warrants for a total issuance of approximately 44 million shares, nearly doubling the company’s existing share capital. None of the instruments are priced at a discount, a rarity for DAT fundraises, suggesting that the incoming investors are targeting long-term growth prospects. As of market closing on September 26, the nominal value of the financing round comes to over JPY 26 billion (approx. USD 180 million), with the first tranche valued at JPY 22.1 billion (approx. USD 150 million).First ETH Treasury in Japan — A Differentiated Strategy Offering Long-Term Returns on EquityAccording to research reports by leading investment banks, the key determinants of success for listed Digital Asset strategies are robust access to capital and a team with operational blockchain expertise. Through this fundraising initiative, Quantum taps into fresh sources of capital and aligns with investors of strong reputation, prompting market expectations of long-term backing.Quantum CEO Francis B. Zhou is no newcomer to the Digital Asset industry, as one of the first institutional investors and operators in the blockchain space. In 2018, Zhou acquired the world’s second largest ETH mining facility, based in Jokkmokk, Sweden. Zhou maintains investments in early stage blockchain projects alongside film and IP holdings in his venture investment portfolio, and brings a network of experienced blockchain operators, including Head of Crypto Strategy Donny Chi.Proceeds from Quantum’s financing initiative will be used to accumulate ETH. Although BTC has demonstrated adoption as a store-of-value, ETH is the foundational asset for blockchain applications, enabling companies like Quantum to explore attractive yield-generating opportunities to drive a blend of organic and inorganic growth for the company’s core treasury and balance sheet.The appeal of yield-bearing strategies is supported by data from the US market, which indicates that listed ETH Treasuries trade at a price-to-book multiple of 7.72x, more than 3 times higher than that of listed BTC Treasuries. More remarkably, the price-to-book of ETH Treasuries is trending upwards, increasing by over 20% within the trading month of September, demonstrating that the market expectations continue to strengthen for listed ETH Treasuries as it relates to long-term returns on equity.Zhou and the Quantum Solutions team have a history of exploring growth frontiers, consequently developing industry traction in AI computing, GPU hosting, and IP gaming. This positions the company to pursue unique opportunities beyond overcrowded sectors in Real World Asset (RWA) space to potentially generate more attractive returns.With the fundraise, Quantum’s notional price-to-book multiple is estimated to be less than 30% of the market median. Assuming that the company can reach its fair value, the structure of the fundraise allows the company to rapidly accelerate its capital accumulation to reach the target of 100,000 ETH within the near term, positioning Quantum among the leading ETH Treasury companies globally.Growth Driven Policies in Japan Encourage Prospects for Long-Term Shareholder ValueConsistent government support for the blockchain industry and increasing clarity in regulations are ushering in a more investor-friendly market for Digital Assets in Japan. Whereas the US market already has ETH Treasury companies such as Bitmine (NASDAQ: BMNR) and SharpLink Gaming (NASDAQ: SBET) achieving significant market cap growth as capital market highlights, Japan lacks a similar listed benchmark. Quantum Solutions’ entry fills this gap, opening a new chapter as "Japan’s first”, and creating conditions for capital inflow and renewed market participation.This financing round, nominally valued at approximately USD 180 million, is a landmark in both the Japanese stock market as well as the crypto-linked equities space. Through the combined endorsement of SIG, ARK, and IAM, Quantum not only secures funding but also international validation under a capital structure optimized to maximize long-term shareholder value. High-profile deals of this caliber further Tokyo as an emerging destination for savvy investors. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Serving the Belt and Road, Setting a New Benchmark for Education, Tianli International School Breaks Ground in Laos National Administrative Center
HONG KONG, Sept 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianli International Holdings Limited (“Tianli International”) and Shenzhen Yidatong Group recently held a formal signing ceremony in Hong Kong to launch their strategic partnership. The agreement, signed at 3:00 PM on September 25th, marks the official start of a high-end international school project in the heart of Laos’s National Administrative Center.This collaboration represents far more than a commercial alliance. It is a key milestone in Tianli International’s dual strategic priorities—“Education AI” and “China International Education Going Global”—and a concrete step in response to China’s Belt and Road Education Initiative and the national blueprint China Education Modernization 2035, which calls for “a new era of educational openness.”Under the agreement, the partners will jointly develop a world-class international education complex featuring two flagship schools:Premier British Boarding School, offering a complete UK curriculum and authentic boarding traditions to nurture the next generation of global leaders from Laos and neighboring countries.Lida Chinese International School, centered on China’s national curriculum, this school will provide both general and academic Chinese tracks, establish a direct pathway to China’s top universities, and promote two-way student exchange programs.The signing ceremony drew congratulations from the China Association for Non-Government Education, which praised the project as a pioneering example of Chinese private education expanding abroad. Guests and witnesses attended from China, Laos, France, Malaysia, Gambia, and other countries.Dr. Luo Shi, Chairman and President of Tianli International, stated that the partnership is both a pivotal milestone in the group’s global strategy and a major advance in its “Education AI + China International Education Going Global” initiative. Looking ahead, the two partners plan to explore innovations in smart-campus infrastructure and AI-driven teaching, delivering high-quality, diversified education options to Southeast Asia and the wider world.Media ContactCompany: Tianli Education (HK ) LimitedContact Person: Dr. Brown FengZhaoEmail: zhaofeng@tianlieducation.com Website: https://www.tianlieducation.com/en/about/index.html Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
“LEQEMBI(R)” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
TOKYO and CAMBRIDGE, Mass., Sept. 29, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (generic name: lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing by the National Medical Products Administration (NMPA) in China.In January 2024, LEQEMBI was approved for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or mild dementia stage of disease (collectively referred to as early AD) in China. After 18 months of a dosing regimen of 10 mg/kg once every two weeks during initiation phase, a transition to the maintenance dosing regimen of 10 mg/kg once every four weeks may be considered or the regimen of 10 mg/kg once every two weeks may be continued.AD is a progressive, relentless disease characterized by formation of protein deposits known as plaques made of amyloid-beta aggregates and neurofibrillary tangles made of tau protein in the brains of people living with AD. It is caused by a continuous underlying neurotoxic process that begins before amyloid plaque accumulation and continues after plaque removal.1,2,3,4 The data show that Aβ protofibrils* and tau tangles play roles in the neurodegeneration process,2,3 and LEQEMBI is the only approved therapy that fights AD in two ways – targeting both amyloid plaque and protofibrils, which can impact tau downstream.Eisai estimates that, as of 2024, there were 17 million patients with MCI or mild dementia due to AD in China in 2024, which is expected to increase with the aging of the population. Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority. In China, Eisai distributes the product and conducts information provision activities through specialized Medical Representatives.* Protofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition.1 Protofibrils cause injury to neurons in the brain, which in turn, can negatively impact cognitive function via multiple mechanisms, not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may prevent the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.4MEDIA CONTACTSEisai Co., Ltd.Public Relations Department+81 (0)3-3817-5120Eisai Europe, Ltd.(UK, Europe, Australia, New Zealand and Russia)EMEA Communications Department+44 (0) 7739 600678EMEA-comms@eisai.netEisai Inc. (U.S.)Libby Holman+ 1-201-753-1945Libby_Holman@eisai.comBiogen Inc.Madeleine Shin+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations Department+81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com About LEQEMBI (generic name: lecanemab)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Protofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of Aβ, having aprimary role in the cognitive decline associated with this progressive, debilitating condition. Lecanemab has been approved in 50 countries and is under regulatory review in 10 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks was approved in China, the U.S. and others, and applications have been filed in 5 countries and regions.LEQEMBI's approvals in these countries were based on Phase 3 data from Eisai's, global Clarity AD clinical trial, in which it met its primary endpoint and all key secondary endpoints with statistically significant results. The primary endpoint was the global cognitive and functional scale, Clinical Dementia Rating Sum of Boxes (CDR-SB).1,5 The U.S. FDA approved Eisai’s Biologics License Application (BLA) for subcutaneous maintenance dosing with LEQEMBI IQLIK in August 2025. In September 2025, the rolling sBLA application to the U.S. FDA for the subcutaneous initiation dosing with LEQEMBI IQLIK was also initiated.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases(NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai. Co., Ltd.), us.eisai.com (for U.S. headquarters: Eisai, Inc.) or www.eisai.eu (for Europe, Middle East, Africa, Russia, Australia and New Zealand headquarters: Eisai Europe Ltd.), and connect with us on X (global and U.S), LinkedIn (for global, U.S. and EMEA) and Facebook (global).About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.For more information, visit: https://www.eisai.com/news/2025/pdf/enews202567pdf.pdf Copyright 2025 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com